rfhg_6765.1

Basic information about the TSS

---

TSS ID: rfhg_6765.1 Species: human Chr: chr1		Start: 51878041 End: 51878041 Strand: -
Source datasets	EPD
Protocol	TSS_database
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000539524.5:1 AK311631:1 GeneID: 4898 HGNC/MGI_ID: HGNC:7995 UniProt_ID: G3V1R5 Nearer transcript ids and distances: AY360265:22 AK299271:-346 view more...

Gene_name: nardilysin convertase Gene_symbol: NRDC Gene_synonyms: hNRD1 hNRD2 Gene_source: HGNC:7995

TATA-Box annotation

---

Distance to TSS:	-1
Nearest PromoterID:	NM_001242361
Entrez ID:	4898
Nearest Unigene:	Hs.584782
Nearest Refseq:	NM_002525
Nearest Ensembl:	ENSG00000078618
Gene Name:	nardilysin convertase
Gene Alias:	NRD1|hNRD1|hNRD2
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.000000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@NRDC p2@NRDC p3@NRDC p4@NRDC p5@NRDC p6@NRDC
Sample		p1@NRDC	p2@NRDC	p3@NRDC	p4@NRDC	p5@NRDC	p6@NRDC
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	15.78	0.00	0.97	0.39	0.00	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	19.62	0.40	0.00	0.00	0.40	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	20.25	0.96	0.00	0.19	0.39	0.96
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	15.39	0.00	0.00	0.42	0.00	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	19.35	0.00	1.12	0.00	0.22	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	13.95	0.19	0.39	0.19	0.19	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	18.74	0.87	0.00	0.22	0.44	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	16.71	0.24	0.73	0.24	0.24	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	14.32	0.43	0.64	0.21	0.64	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	13.91	1.16	0.00	0.58	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	19.40	1.21	0.81	0.40	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	15.45	0.41	1.22	0.41	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	15.96	0.48	0.00	0.32	0.16	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	16.69	0.30	0.15	0.00	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	14.05	0.44	0.00	0.22	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	11.82	0.25	0.00	0.00	0.00	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	11.79	0.66	0.00	0.22	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	14.34	0.00	0.00	0.42	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	14.93	0.00	0.00	0.53	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	15.65	0.75	0.00	0.00	0.60	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	14.43	0.00	0.00	0.00	0.13	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	12.43	0.35	0.17	0.17	0.00	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	16.67	0.52	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	13.10	0.24	0.00	0.24	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	12.64	0.52	0.00	0.26	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	10.44	0.00	0.00	0.32	0.32	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	15.38	0.00	0.00	0.00	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	16.03	0.71	0.24	0.00	0.00	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	13.89	0.00	0.00	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	14.12	0.00	0.18	0.00	0.18	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	11.93	0.00	0.21	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	13.29	0.20	0.00	0.00	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	14.56	0.42	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	16.16	0.33	0.00	0.16	0.16	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	14.59	0.19	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	14.56	0.38	0.00	0.19	0.00	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	11.85	0.20	0.00	0.20	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	11.28	0.40	0.00	0.20	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	11.61	0.00	0.00	0.00	0.27	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	14.16	0.00	0.24	0.00	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	12.47	0.00	0.00	0.00	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	14.05	0.29	0.15	0.00	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	10.12	0.00	0.00	0.21	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	11.19	0.00	0.00	0.17	0.17	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	13.65	0.00	0.20	0.20	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	8.61	0.70	0.00	0.23	0.00	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	7.20	0.24	0.00	0.00	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	10.13	0.30	0.30	0.00	0.00	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	9.57	0.48	0.24	0.00	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	8.49	0.20	0.40	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	12.09	0.61	0.00	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	8.89	0.89	0.22	0.00	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	181.90	0.00	0.00	0.00	0.00	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	8.16	0.00	0.00	0.35	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	10.60	0.33	0.00	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	26.85	6.71	0.84	0.00	0.00	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	11.94	0.00	0.00	0.00	0.00	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	9.08	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	6.10	0.32	0.32	0.00	0.00	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	10.06	0.00	0.31	0.63	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	8.46	0.71	0.00	0.00	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	11.78	0.56	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	13.53	1.59	0.00	0.80	0.00	5.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	7.81	0.34	0.34	0.00	0.00	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	6.82	0.65	0.32	0.00	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	8.52	1.06	0.00	0.35	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	274.79	16.16	0.00	0.00	0.00	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	189.54	15.79	7.90	0.00	0.00	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	9.26	0.00	0.00	0.00	0.00	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	9.92	0.50	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	9.38	0.94	0.47	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	16.56	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	16.09	0.31	0.31	0.00	0.00	1.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	12.84	0.31	0.00	0.00	0.31	0.31
Adipocyte - breast, donor1	11376-118A8	34.05	0.79	0.95	0.32	0.48	0.16
Adipocyte - breast, donor2	11327-117E4	31.76	2.73	2.09	0.16	0.32	1.76
Adipocyte - omental, donor1	11473-119C6	43.89	0.13	1.02	0.38	0.00	0.38
Adipocyte - omental, donor2	11474-119C7	20.93	1.49	0.75	1.49	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	22.44	1.67	0.67	0.67	0.33	1.00
Adipocyte - perirenal, donor1	11476-119C9	15.95	0.00	0.00	0.00	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	12.09	0.00	1.10	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	29.81	0.45	0.00	0.00	0.90	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	22.07	0.70	0.35	0.00	0.00	0.70
Adipocyte differentiation, day04, donor1	13019-139D4	45.37	0.00	0.39	0.78	0.20	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	25.48	1.03	0.00	0.26	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	35.96	1.12	0.84	0.84	0.28	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	33.51	0.59	0.00	1.18	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	78.82	0.72	1.61	0.64	1.13	0.48
Adipocyte differentiation, day08, donor2	13023-139D8	30.66	0.32	0.65	0.65	0.65	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	21.33	0.00	0.53	0.00	0.00	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	36.72	1.11	2.23	0.00	0.00	1.67
Adipocyte differentiation, day12, donor1	13021-139D6	43.67	0.83	1.66	0.00	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	25.12	0.50	0.75	0.25	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	30.76	0.33	0.33	0.33	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	48.11	0.30	2.13	0.00	1.22	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	10.39	0.44	0.00	0.44	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	3.23	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	5.99	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	12.05	0.36	0.00	0.00	0.18	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	10.04	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	6.99	0.21	0.21	0.00	0.21	0.00
Anulus Pulposus Cell, donor1	11248-116E6	53.89	0.34	0.80	1.72	0.34	0.11
Anulus Pulposus Cell, donor2	11463-119B5	25.23	1.47	0.00	0.73	0.49	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	13.03	0.45	0.00	0.00	0.45	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	19.97	0.43	0.43	0.43	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	21.40	0.00	0.00	0.00	0.00	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	17.34	0.00	0.00	0.00	0.00	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	16.44	1.26	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	15.18	1.32	0.00	0.00	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	16.24	0.65	0.00	0.32	0.65	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	21.36	0.97	0.49	0.97	0.00	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	24.35	1.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	20.34	0.00	0.00	0.00	0.38	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	10.89	1.45	0.73	0.00	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	11.28	1.25	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	32.45	0.33	0.82	0.33	0.16	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	12.28	0.00	0.00	0.00	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	17.19	0.00	0.15	0.60	0.45	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	16.61	0.54	0.54	0.00	0.00	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	21.16	0.19	0.57	0.00	0.38	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	23.52	0.53	1.07	0.00	0.27	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	17.56	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	22.89	0.33	0.33	0.17	0.83	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	21.61	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	0.00	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	19.55	0.51	0.69	0.69	0.34	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	20.97	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	14.08	0.00	0.49	0.49	0.00	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	19.73	0.00	0.76	0.38	0.76	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	24.23	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	18.81	0.00	0.57	0.00	1.14	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	16.67	0.43	0.86	0.21	0.64	0.86
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	14.19	0.77	0.52	0.26	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	14.55	0.47	0.00	0.47	0.47	2.35
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	22.83	0.64	0.00	0.32	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	21.40	0.00	1.43	0.71	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	14.62	0.00	0.00	1.17	0.58	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	19.57	0.00	0.30	0.30	0.00	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	24.95	0.00	0.00	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	17.80	0.51	0.51	0.51	0.51	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	20.12	1.02	0.00	0.00	0.00	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	13.98	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	16.83	0.00	0.43	0.43	0.43	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	18.21	0.00	0.85	0.42	0.85	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	17.11	0.58	0.29	0.29	0.00	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	15.12	0.94	0.00	0.00	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	18.65	0.17	1.19	0.68	1.36	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	0.00	0.00	0.00	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	21.13	0.00	2.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	13.08	0.21	0.64	0.21	0.43	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	22.86	1.20	1.20	0.00	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	10.21	0.00	0.73	0.73	1.46	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	16.09	0.00	0.23	0.46	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	15.30	5.10	2.55	0.00	0.00	5.10
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	18.30	0.25	1.02	0.00	0.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	20.85	0.62	0.21	1.03	0.00	0.62
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	26.01	0.00	0.31	0.00	0.00	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	19.60	0.48	0.48	0.00	0.48	2.39
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	20.18	0.00	0.67	0.44	0.44	1.33
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	10.68	0.00	0.00	3.05	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	14.95	0.00	0.55	0.00	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	23.04	0.53	0.79	0.53	0.26	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	17.45	0.00	0.00	0.00	0.00	0.73
Astrocyte - cerebellum, donor1	11500-119F6	10.19	0.00	0.25	1.35	0.00	0.00
Astrocyte - cerebellum, donor2	11580-120F5	6.16	0.00	0.00	0.17	0.17	0.00
Astrocyte - cerebellum, donor3	11661-122F5	4.61	0.42	0.00	0.21	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	38.34	0.35	0.00	1.74	1.05	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	46.43	1.46	0.97	1.46	0.81	0.81
Astrocyte - cerebral cortex, donor3	11392-118C6	42.06	0.89	0.45	0.75	1.49	1.04
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	59.41	2.98	1.03	1.26	2.52	0.92
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	54.37	2.00	1.50	1.25	1.00	0.88
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	54.51	1.25	0.80	0.91	1.25	0.68
Basophils, donor1	12241-129G9	16.22	0.00	0.00	0.78	0.78	0.00
Basophils, donor2	12242-129H1	31.75	0.72	0.72	0.36	1.08	0.00
Basophils, donor3	12243-129H2	20.29	0.59	0.00	0.29	3.67	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	5.17	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	2.74	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	15.06	0.63	0.00	0.63	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	12.27	0.00	0.21	0.42	1.04	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	19.34	0.23	0.23	0.92	0.46	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	18.17	0.72	0.18	0.72	1.26	1.44
Burkitt's lymphoma cell line:DAUDI	10422-106C8	53.79	1.24	2.16	3.09	1.55	0.52
Burkitt's lymphoma cell line:RAJI	10476-106I8	55.90	0.93	0.23	1.40	1.86	0.93
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	43.81	0.00	0.32	0.32	1.92	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	113.76	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	30.43	0.00	0.00	1.69	2.25	0.00
CD14+ Monocytes, donor2	11305-117B9	29.14	2.04	0.37	0.19	0.74	1.48
CD14+ Monocytes, donor3	11381-118B4	25.91	0.88	0.22	0.66	1.10	1.10
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	53.21	0.28	0.85	1.13	0.85	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	56.86	0.76	0.38	0.76	1.90	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	63.78	0.00	0.00	1.31	3.29	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	27.75	0.72	0.43	0.29	0.58	0.43
CD14+ monocytes - mock treated, donor2	11873-125C1	17.80	0.30	0.60	0.00	0.00	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	19.43	0.47	0.47	0.95	0.47	0.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	19.92	0.67	0.67	0.33	0.00	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	22.63	0.28	0.55	0.28	0.00	1.10
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	21.57	0.74	0.99	0.74	0.00	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	30.54	1.37	0.59	1.17	0.20	1.17
CD14+ monocytes - treated with BCG, donor2	11870-125B7	32.94	0.71	0.71	0.18	0.71	1.25
CD14+ monocytes - treated with BCG, donor3	11880-125C8	47.88	0.22	0.87	0.44	0.65	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	23.18	0.23	0.47	0.47	0.47	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	23.23	0.53	0.00	1.06	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	23.30	0.00	0.00	1.11	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	24.54	1.49	0.45	0.15	0.00	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	26.14	0.80	0.40	0.40	0.00	0.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	34.14	0.21	0.62	0.00	0.21	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	27.00	1.37	0.69	0.23	0.92	1.14
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	28.73	0.00	0.45	0.00	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	19.64	0.44	0.87	0.44	0.00	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	33.62	0.81	1.08	0.27	0.27	0.81
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	41.00	0.70	1.22	0.00	0.17	1.92
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	35.35	1.26	0.84	0.42	0.00	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	22.41	0.73	0.73	0.55	0.00	1.29
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	21.14	0.35	0.70	1.06	0.35	2.82
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	27.20	0.88	0.88	0.88	0.88	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	27.38	0.70	2.09	0.70	0.52	2.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	31.22	0.74	1.12	0.00	0.37	2.23
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	40.31	0.43	0.65	0.22	0.65	1.29
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	26.21	1.64	0.00	0.41	1.23	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	26.43	1.16	1.16	0.23	0.00	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	25.06	0.23	0.23	0.70	0.46	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	27.46	0.22	0.00	0.22	0.00	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	29.57	0.00	0.46	0.92	0.92	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	23.39	0.00	0.22	0.43	0.65	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	51.39	0.31	0.47	0.16	0.00	0.78
CD14+CD16- Monocytes, donor2	11799-124C8	40.87	0.35	0.17	0.52	0.70	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	78.71	1.34	0.45	1.78	0.45	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	29.09	0.00	0.00	0.26	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	22.18	0.00	0.00	1.10	0.22	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	27.58	0.21	0.00	1.05	1.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	28.45	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	50.85	0.00	0.00	2.03	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	41.42	0.00	0.00	1.04	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	51.70	0.00	0.00	0.00	0.53	1.60
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	55.75	0.54	0.00	2.14	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	37.90	0.70	0.00	2.11	0.00	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	43.92	0.00	0.00	0.78	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	43.50	0.00	0.00	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	18.90	2.47	0.00	1.64	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	15.23	2.18	0.00	0.73	1.45	0.73
CD19+ B Cells, donor3	11705-123B4	13.63	0.00	0.50	2.02	1.51	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	126.07	0.81	3.64	2.02	2.42	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	85.49	0.00	2.00	0.80	2.00	0.40
CD34+ Progenitors, donor1	11545-120B6	29.12	0.00	0.00	0.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	23.03	0.00	0.00	0.56	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	46.97	0.38	0.75	0.75	2.63	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	50.96	0.23	1.13	0.90	1.13	0.00
CD4+ T Cells, donor1	11225-116C1	43.92	1.43	0.00	2.14	1.07	0.36
CD4+ T Cells, donor2	11306-117C1	30.62	3.67	0.00	0.61	0.00	0.61
CD4+ T Cells, donor3	11382-118B5	28.36	1.52	0.30	0.91	0.61	1.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	56.15	0.77	0.51	0.77	0.00	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	53.23	0.22	0.67	0.67	1.12	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	45.42	0.57	0.00	1.44	0.57	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	43.14	0.00	0.47	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	35.12	0.00	0.00	0.70	0.70	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	16.48	3.30	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	40.18	0.58	0.72	0.58	0.00	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	36.60	0.51	0.34	0.68	0.51	1.53
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	29.66	0.97	0.48	1.29	1.61	0.97
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	37.21	0.00	0.00	1.34	0.90	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	35.99	0.35	0.35	0.35	0.70	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	51.92	1.76	0.44	0.88	1.76	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	49.75	0.00	0.00	0.84	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	27.01	0.62	0.21	0.83	0.83	0.83
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	22.72	0.00	0.00	0.67	0.33	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	45.68	0.82	0.27	0.00	0.27	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	60.56	0.00	0.00	3.75	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	43.04	1.79	0.00	0.00	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	60.64	1.11	0.19	0.00	0.19	1.11
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	32.71	0.22	0.87	0.87	0.65	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	36.99	0.00	0.42	2.10	1.47	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	38.43	0.00	1.01	0.00	0.00	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	32.49	0.00	0.00	0.43	0.43	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	39.22	1.74	0.00	1.74	0.44	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	48.50	0.00	0.00	1.48	0.49	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	44.31	0.92	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	46.06	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	52.62	0.00	0.00	1.66	0.28	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	52.51	0.25	0.25	2.45	0.49	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	69.30	0.00	1.54	3.08	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	61.95	0.72	0.36	1.07	1.07	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	70.63	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	34.05	0.65	0.00	2.95	1.31	0.00
CD8+ T Cells, donor2	11307-117C2	21.40	1.88	0.38	1.13	0.75	0.75
CD8+ T Cells, donor3	11383-118B6	30.55	0.76	0.00	2.27	2.02	1.77
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	13.76	0.23	0.23	0.00	0.00	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	11.98	0.48	0.00	0.24	0.00	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	19.42	0.27	0.27	0.27	0.00	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	9.91	0.00	0.00	0.60	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	11.04	0.72	0.24	0.72	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	10.23	0.00	0.23	0.68	0.00	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	11.73	0.22	0.22	0.22	0.00	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	15.53	0.53	0.26	0.26	0.00	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	18.29	0.23	1.17	0.47	0.00	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	16.91	0.00	0.30	0.60	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	19.46	0.29	0.58	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	21.31	0.80	0.27	0.80	0.00	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	21.89	0.00	0.00	0.88	0.00	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	19.13	0.00	0.91	0.46	0.00	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	12.68	0.00	0.75	0.00	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	16.93	0.00	0.36	0.72	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	12.66	0.29	0.29	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	15.08	0.00	0.00	0.47	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	17.43	0.63	0.63	0.63	0.00	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	17.22	0.00	0.31	0.62	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	21.80	0.00	0.64	0.96	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	17.21	0.38	0.38	0.38	0.00	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	17.73	0.00	0.00	0.00	0.00	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	18.15	0.76	0.00	0.76	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	33.72	0.00	0.00	0.80	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	28.68	0.70	1.40	0.70	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	29.05	0.00	0.00	0.00	0.00	2.00
Cardiac Myocyte, donor1	11525-119I4	27.42	0.00	0.00	1.83	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	20.26	0.49	0.49	0.00	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	29.36	0.32	0.32	0.32	0.74	0.11
Chondrocyte - de diff, donor1	11261-116G1	22.88	0.00	0.35	0.00	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	19.55	0.36	0.00	0.71	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	27.08	0.46	0.23	0.23	0.91	0.34
Chondrocyte - re diff, donor2	11339-117F7	76.99	0.00	1.79	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	19.01	0.00	0.00	0.81	1.62	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	61.51	0.69	0.57	1.15	0.57	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	35.27	0.21	0.64	0.21	0.64	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	38.85	0.44	0.53	0.80	0.71	0.62
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	32.10	0.46	1.19	2.38	2.48	0.28
Corneal Epithelial Cells, donor1	11526-119I5	3.95	0.00	0.00	0.22	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	7.96	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	11.76	0.51	0.00	0.51	0.51	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	39.95	0.17	0.99	1.16	0.50	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	46.37	0.00	1.26	1.58	0.32	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	27.61	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	33.91	0.97	0.54	0.65	1.19	1.08
Dendritic Cells - plasmacytoid, donor1	11228-116C4	53.30	0.34	0.68	1.37	2.39	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	67.25	0.00	0.00	0.65	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	41.14	0.48	0.97	2.42	0.48	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	28.68	0.17	0.83	0.33	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	13.50	0.00	0.59	0.00	1.17	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	25.73	0.28	0.28	0.28	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	28.31	0.00	0.79	0.00	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	13.09	0.00	0.00	0.29	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	20.70	1.18	0.94	0.94	1.18	0.47
Endothelial Cells - Artery, donor3	11413-118E9	22.97	1.40	0.35	0.00	0.53	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	24.83	0.00	0.00	0.22	0.22	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	36.82	0.00	0.61	0.61	0.91	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	29.04	0.28	0.00	0.56	1.13	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	10.70	0.00	0.00	0.59	0.30	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	19.79	0.00	0.52	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	9.78	0.43	0.14	0.43	0.28	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	26.41	0.00	0.80	0.40	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	9.43	0.52	0.00	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	76.54	1.37	1.62	0.87	0.25	0.50
Endothelial Cells - Umbilical vein, donor2	11324-117E1	51.06	0.65	1.30	0.65	0.65	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	56.55	0.24	1.22	0.61	1.83	0.98
Endothelial Cells - Vein, donor1	11267-116G7	7.96	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	18.16	0.00	0.00	1.40	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	23.55	0.79	0.16	0.47	1.26	0.16
Eosinophils, donor1	12244-129H3	30.49	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	217.83	0.00	4.95	4.95	4.95	1.65
Eosinophils, donor3	12246-129H5	153.37	0.00	0.00	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	7.09	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	36.54	1.23	0.82	0.00	0.82	2.05
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	10.07	0.11	0.11	0.11	0.00	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	17.12	0.33	0.11	0.43	0.11	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	36.63	1.58	0.73	0.85	0.00	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	79.84	0.27	2.18	1.36	0.68	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	32.70	2.00	0.74	0.53	0.11	0.53
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	36.63	1.58	0.79	1.58	1.05	1.58
Fibroblast - Aortic Adventitial, donor3	11401-118D6	40.53	0.33	0.00	0.66	0.66	0.00
Fibroblast - Cardiac, donor1	11268-116G8	19.51	0.45	0.45	0.00	0.91	0.00
Fibroblast - Cardiac, donor2	11345-117G4	18.19	0.00	0.76	0.00	0.00	0.76
Fibroblast - Cardiac, donor3	11417-118F4	16.56	0.47	0.16	0.63	0.00	0.16
Fibroblast - Cardiac, donor4	11452-119A3	72.44	0.30	1.82	1.52	1.82	0.00
Fibroblast - Cardiac, donor5	11456-119A7	36.55	0.89	1.40	0.38	0.25	0.76
Fibroblast - Cardiac, donor6	11460-119B2	30.77	0.91	0.61	0.76	0.45	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	22.38	0.27	0.40	0.54	0.00	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	25.02	0.86	0.43	0.00	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	24.90	2.93	1.46	0.00	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	20.76	0.23	0.00	0.46	0.92	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	52.41	0.68	0.85	0.51	0.51	0.17
Fibroblast - Dermal, donor1	11269-116G9	25.83	0.94	0.00	0.47	0.94	0.23
Fibroblast - Dermal, donor2	11346-117G5	36.79	0.94	0.94	0.47	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	34.94	0.36	0.85	0.48	0.48	0.73
Fibroblast - Dermal, donor4	11450-119A1	45.90	1.92	1.58	0.68	1.70	0.34
Fibroblast - Dermal, donor5	11454-119A5	39.43	2.09	1.05	0.70	0.52	0.70
Fibroblast - Dermal, donor6	11458-119A9	49.86	1.14	0.49	2.44	1.30	0.49
Fibroblast - Gingival, donor1	11237-116D4	88.91	0.83	1.46	1.04	0.42	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	49.52	0.79	1.05	0.26	0.26	1.05
Fibroblast - Gingival, donor2	11318-117D4	52.32	1.71	0.79	0.13	1.58	1.45
Fibroblast - Gingival, donor3	11394-118C8	80.64	1.35	0.48	1.16	1.74	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	42.59	0.00	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	33.30	0.88	0.35	0.18	0.18	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	69.22	0.62	1.71	0.62	0.31	0.94
Fibroblast - Gingival, donor6 (control)	11922-125H5	58.28	0.81	1.49	0.54	0.41	1.22
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	34.23	0.00	1.41	0.35	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	52.36	1.02	1.02	0.29	0.15	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	56.45	0.95	1.77	1.09	0.55	0.95
Fibroblast - Gingival, donor8 (control)	11926-125H9	59.78	1.54	1.21	0.99	0.77	0.88
Fibroblast - Gingival, donor9 (control)	11927-125I1	37.86	0.15	0.15	0.15	0.00	0.59
Fibroblast - Lung, donor1	11270-116H1	6.80	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	41.78	0.00	1.49	1.49	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	31.23	0.42	0.63	0.42	0.63	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	17.49	0.00	0.00	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	8.39	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	3.08	0.28	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	34.51	0.00	0.41	0.81	0.00	0.41
Fibroblast - Mammary, donor2	11620-122A9	11.98	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	72.74	0.78	2.13	1.36	0.97	0.78
Fibroblast - Periodontal Ligament, donor2	11319-117D5	95.86	3.19	2.28	0.61	2.58	1.67
Fibroblast - Periodontal Ligament, donor3	11395-118C9	128.51	1.84	3.37	1.22	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	32.44	0.38	0.76	0.00	0.38	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	47.52	1.08	1.35	0.27	0.00	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	38.74	0.93	0.23	0.35	0.00	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	28.08	0.55	0.88	0.77	0.33	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	32.92	0.20	0.81	0.61	0.41	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	14.03	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	37.56	0.79	0.40	0.40	1.98	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	51.60	1.98	0.40	1.98	0.79	1.59
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	32.33	0.18	0.36	0.36	0.36	0.89
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	50.65	0.39	1.18	0.59	0.00	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	36.70	0.90	1.20	0.60	1.20	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	43.40	0.54	0.97	0.54	0.76	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	43.78	0.25	1.27	0.25	1.27	1.01
Fibroblast - skin normal, donor1	11553-120C5	42.33	0.33	0.33	0.33	0.16	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	69.17	0.20	1.00	1.20	4.21	0.60
Fibroblast - skin normal, donor2	11561-120D4	35.06	0.70	0.70	1.00	1.11	0.30
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	65.89	1.51	0.91	1.51	0.60	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	52.03	0.58	0.50	0.66	0.17	0.58
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	42.22	1.71	0.51	1.03	0.34	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	31.86	0.66	1.31	1.97	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	41.12	0.43	0.85	1.28	0.11	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	42.17	0.51	0.34	0.34	0.17	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	27.60	0.00	0.47	0.16	0.31	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	620.47	22.16	22.16	22.16	22.16	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	25.27	0.87	0.00	0.00	0.00	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	34.32	0.35	1.39	0.35	0.17	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	41.64	0.78	1.56	0.00	0.52	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	40.37	0.00	2.30	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	29.86	0.77	2.30	0.77	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	24.88	1.28	1.91	0.64	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	55.91	1.43	1.43	0.57	3.42	2.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	27.30	0.28	0.00	0.55	1.93	1.38
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	28.77	0.46	1.37	0.00	0.91	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	43.39	2.58	0.99	0.59	1.59	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	31.72	0.53	0.53	0.79	0.26	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	32.61	0.65	0.00	0.65	0.00	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	59.70	3.54	1.77	0.44	0.44	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	35.61	1.41	1.27	0.71	0.71	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	31.52	1.35	0.99	1.35	0.62	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	32.24	1.34	1.88	0.27	0.00	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	26.51	1.12	0.37	0.50	0.37	0.87
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	27.13	0.97	1.25	0.97	0.69	1.38
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	28.06	0.81	1.63	0.61	0.61	1.63
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	31.49	1.37	0.23	0.46	1.14	1.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	33.88	0.87	1.00	0.50	0.75	1.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	36.50	1.75	0.44	0.66	0.66	1.31
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	24.52	1.48	0.59	0.00	1.18	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	30.36	1.27	0.64	0.95	0.79	0.95
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	30.39	0.67	0.67	0.22	0.45	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	24.40	0.81	0.60	0.20	0.60	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	31.55	0.85	1.19	1.02	0.34	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	57.02	0.53	2.04	0.35	0.27	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	38.08	0.10	0.42	0.21	0.52	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	25.45	0.17	0.17	0.85	0.34	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	24.34	1.22	0.66	0.55	0.66	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	43.10	0.50	1.58	0.33	0.33	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	30.83	0.00	1.43	0.61	0.00	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	27.64	0.41	0.41	0.62	1.24	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	25.13	0.69	0.12	0.69	0.69	1.04
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	29.68	0.33	1.17	0.33	0.83	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	18.08	0.88	0.66	0.22	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	27.80	0.74	0.12	0.49	1.11	1.23
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	26.10	0.32	0.16	0.16	1.13	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	28.22	0.96	0.00	0.32	0.32	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	19.80	0.57	0.76	0.85	0.19	0.85
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	20.25	0.47	0.95	0.32	0.16	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	26.15	1.22	0.00	0.00	0.30	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	22.68	0.73	0.52	0.84	0.63	0.73
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	21.52	0.66	0.66	0.00	0.66	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	24.13	0.28	0.56	0.56	0.28	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	21.30	0.46	0.93	0.93	0.09	0.93
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	18.45	0.27	1.07	0.53	0.53	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	20.81	0.46	0.92	0.00	0.77	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	17.10	0.78	0.78	0.65	0.39	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	25.21	0.27	0.27	0.00	0.81	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	22.49	1.11	0.37	0.74	0.55	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	19.74	1.10	0.88	0.66	0.44	1.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	39.67	0.00	0.00	0.00	1.98	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	32.45	0.26	0.53	0.40	0.40	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	25.62	0.40	0.40	0.81	0.40	1.41
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	59.98	0.00	0.25	1.02	2.03	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	52.15	1.99	2.99	1.79	1.39	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	36.98	1.23	1.54	1.08	0.62	1.85
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	52.58	1.02	2.86	2.45	0.82	1.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	29.73	0.00	1.56	0.31	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	33.34	0.28	0.85	0.28	0.57	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	48.43	0.46	4.15	0.46	0.92	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	19.80	2.47	2.47	4.95	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	42.55	0.39	1.93	0.00	0.00	2.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	36.90	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	45.21	3.48	1.74	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	31.25	2.93	1.30	1.30	0.98	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	35.83	1.65	2.88	1.65	0.82	1.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	49.98	6.66	0.00	0.00	0.00	10.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	28.52	0.28	0.84	0.84	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	33.01	0.00	0.98	0.65	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	34.39	2.52	0.00	1.68	0.00	5.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	28.63	0.95	1.27	0.64	0.64	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	31.25	0.34	1.36	0.34	1.02	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	37.59	0.00	2.09	0.00	2.09	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	35.51	1.15	1.15	1.15	2.29	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	24.57	0.59	0.30	0.89	0.59	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	33.88	1.69	0.00	0.00	0.00	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	32.31	1.24	1.24	0.83	1.66	2.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	32.22	0.69	1.61	0.92	0.46	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	26.34	5.27	0.00	0.00	5.27	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	21.53	0.38	1.15	0.77	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	26.40	0.65	0.98	0.65	0.65	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	19.40	0.67	0.67	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	36.99	1.16	0.77	0.39	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	25.33	0.00	1.37	1.03	0.34	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	24.85	4.97	0.00	0.00	0.00	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	28.78	0.47	0.00	1.89	0.94	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	26.55	0.60	0.00	1.21	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	24.42	0.51	0.00	1.53	1.02	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	32.70	0.80	0.00	0.00	1.20	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	29.60	0.00	0.00	1.48	0.99	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	27.15	1.18	0.00	0.00	1.18	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	22.75	1.17	0.00	0.58	0.58	1.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	33.79	0.44	0.44	0.44	1.32	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	23.74	0.85	0.85	0.85	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	23.88	1.79	0.00	0.60	0.00	2.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	19.90	0.97	0.97	0.00	0.00	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	9.13	0.00	1.14	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	19.96	0.42	0.42	0.00	0.00	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	19.12	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	21.57	0.63	0.00	0.63	1.27	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	14.62	0.00	0.00	0.00	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	35.74	1.28	1.28	0.35	0.58	1.04
Hep-2 cells mock treated, biol_rep2	11899-125E9	34.44	0.51	1.18	1.01	0.51	0.68
Hep-2 cells mock treated, biol_rep3	11900-125F1	32.76	0.68	0.68	0.46	0.23	1.14
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	32.25	0.66	2.51	0.77	0.44	0.77
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	35.03	0.43	0.86	1.07	0.21	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	26.48	0.65	1.29	1.08	0.22	1.72
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	35.87	0.75	1.62	0.75	0.25	0.50
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	27.79	1.20	0.86	0.69	0.51	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	26.91	0.96	1.60	0.32	0.32	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	9.51	0.00	0.56	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	9.52	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	5.29	2.64	0.00	0.00	0.00	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	10.58	0.35	0.71	0.35	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	6.54	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	22.38	0.35	0.70	0.52	1.22	0.52
Hepatocyte, donor1	11523-119I2	44.79	3.63	2.42	0.00	3.63	3.63
Hepatocyte, donor2	11603-120I1	64.64	2.15	0.00	0.00	0.00	3.23
Hepatocyte, donor3	11684-122I1	52.76	2.45	0.61	0.61	0.61	4.91
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	37.20	0.65	0.65	1.96	0.00	4.57
Intestinal epithelial cells (polarized), donor1	11246-116E4	43.00	1.05	1.05	0.70	0.87	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	30.05	0.14	0.27	0.41	0.69	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	15.92	0.00	0.00	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	8.31	0.00	1.38	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	20.02	0.00	2.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	28.19	0.00	2.56	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	24.36	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	10.00	0.00	0.00	0.00	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	14.56	0.00	6.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	12.20	0.00	0.00	0.00	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	31.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	20.79	0.63	1.89	0.00	0.00	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	24.75	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	23.26	0.65	1.94	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	9.66	0.00	1.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	18.74	0.00	2.44	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	18.05	0.00	1.26	0.00	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	23.31	0.00	0.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	14.77	0.00	2.77	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	16.05	0.47	1.89	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	11.79	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	16.14	1.08	1.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	5.08	0.00	1.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	14.67	0.00	0.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	23.69	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	18.57	0.00	2.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	13.27	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	22.84	0.93	1.85	0.00	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	7.02	0.00	1.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	18.86	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	14.60	0.70	0.00	0.00	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	15.49	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	29.18	0.00	6.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	14.82	0.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	40.50	0.00	0.00	0.00	4.50	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	6.97	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	11.73	1.07	1.07	0.00	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	20.78	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	2.85	0.00	0.00	0.00	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	9.20	0.92	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	21.18	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	13.75	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	27.91	0.49	1.39	0.24	0.08	0.24
Keratinocyte - epidermal, donor2	11349-117G8	9.96	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	37.96	1.14	0.85	0.47	1.04	0.85
Keratinocyte - oral, donor1	11251-116E9	53.47	0.57	0.23	1.36	1.48	0.23
Keratocytes, donor1	11527-119I6	14.10	0.00	0.00	0.34	0.00	0.00
Keratocytes, donor2	11607-120I5	4.69	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	24.11	0.79	0.20	0.79	0.40	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	24.18	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	16.18	1.08	0.00	0.00	1.08	2.16
Lens Epithelial Cells, donor2	11609-120I7	38.64	0.46	0.58	0.69	1.50	0.58
Lens Epithelial Cells, donor3	11690-122I7	42.89	0.30	1.01	0.50	1.11	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	21.58	0.36	0.71	0.36	0.83	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	13.95	0.28	0.00	1.12	0.00	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	21.88	1.26	0.47	0.16	0.00	0.94
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	11.29	0.00	0.00	0.54	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	14.50	0.00	0.32	0.00	0.00	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	11.43	0.43	0.11	0.43	0.32	0.43
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	17.65	0.41	0.41	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	5.31	0.51	0.00	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	14.22	0.56	0.28	0.28	0.14	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	11.87	0.00	0.79	0.79	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	18.61	0.19	0.19	0.39	0.00	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	5.00	0.00	0.37	0.37	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	17.07	0.35	0.00	0.00	0.00	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	14.55	0.48	0.72	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	11.40	0.41	0.00	0.14	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	14.78	0.62	0.31	0.31	0.31	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	7.79	0.00	0.31	0.31	0.00	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	9.15	0.00	0.00	0.00	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	12.84	0.66	0.33	0.33	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	8.79	0.00	0.29	0.59	0.00	0.88
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	5.48	0.25	0.00	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	15.52	0.00	0.97	0.48	0.00	1.45
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	16.16	0.00	0.27	0.00	0.54	0.81
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	13.47	0.30	0.30	0.30	0.15	0.61
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	12.44	0.52	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	16.54	0.42	0.00	0.21	0.21	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	12.03	0.30	0.30	0.15	0.30	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	13.07	0.69	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	14.86	0.38	0.19	0.19	0.00	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	9.97	0.21	0.21	0.21	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	14.54	0.97	0.00	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	14.22	0.00	0.66	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	7.19	0.12	0.25	0.12	0.12	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	25.91	0.00	0.00	0.00	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	10.62	0.00	0.49	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	7.84	0.69	0.27	0.14	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	16.08	0.32	0.00	0.32	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	20.39	0.00	0.61	0.00	0.00	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	19.32	0.28	0.28	0.56	0.00	0.70
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	10.31	0.36	0.00	0.36	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	11.15	0.00	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	5.60	0.16	0.00	0.16	0.00	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	15.04	0.72	0.72	0.36	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	13.72	0.00	0.98	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	5.41	0.47	0.00	0.00	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	18.44	0.00	0.50	0.25	0.50	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	6.92	0.00	0.26	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	8.65	0.30	0.30	0.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	9.06	0.00	0.00	2.27	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	7.67	0.00	0.00	0.00	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	7.42	0.74	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	11.42	0.85	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	4.92	0.70	0.00	0.00	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	6.54	0.00	0.00	0.00	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	10.82	0.00	0.00	0.00	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	5.95	0.00	0.00	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	13.12	0.00	0.45	0.23	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	10.47	0.29	0.00	0.58	0.00	1.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	11.25	0.90	0.00	0.00	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	16.53	0.14	0.41	0.41	0.14	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	9.24	0.51	0.00	0.00	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	12.00	0.00	0.00	0.35	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	7.33	1.33	0.00	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	14.26	0.00	0.00	0.51	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	13.61	0.80	0.27	1.07	1.07	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	20.41	0.57	0.19	0.19	0.38	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	10.43	0.61	0.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	13.05	0.82	0.00	0.82	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	20.20	0.21	0.42	0.00	1.04	0.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	21.30	0.28	0.28	1.12	0.00	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	15.46	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	17.13	2.32	0.87	0.87	0.58	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	15.25	0.60	0.90	0.30	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	17.15	0.00	0.55	0.55	1.11	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	19.44	0.71	0.35	0.71	0.35	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	19.18	0.00	0.37	1.11	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	11.51	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	12.28	0.38	0.00	0.77	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	11.89	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	10.67	0.00	0.00	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	12.65	0.45	0.00	0.00	0.45	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	12.93	1.44	0.00	0.00	0.00	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	7.47	0.75	0.00	0.00	1.49	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	14.49	1.49	1.11	0.00	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	14.21	0.43	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	13.70	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	16.33	1.00	1.00	0.67	0.33	1.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	13.27	0.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	7.11	0.71	0.00	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	9.62	0.00	0.34	0.00	0.34	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	12.35	0.00	0.00	0.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	6.73	0.00	1.35	0.00	1.35	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	13.71	0.00	0.00	0.74	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	19.77	0.00	0.00	1.16	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	9.52	1.06	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	10.40	1.20	0.00	0.40	0.40	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	18.17	2.18	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	10.73	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	11.84	0.99	0.49	0.00	0.99	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	10.35	0.00	0.00	0.00	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	11.56	0.00	1.01	0.00	0.50	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	10.36	0.45	0.00	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	10.33	0.00	0.00	0.00	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	15.14	1.34	0.89	0.89	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	11.34	1.17	0.39	0.00	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	8.58	1.32	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	11.94	0.52	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	14.00	0.44	0.88	0.00	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	8.95	1.68	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	8.83	0.44	0.00	0.00	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	10.03	0.77	0.39	0.39	1.54	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	11.65	0.51	0.00	0.51	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	13.94	0.00	0.00	0.96	0.96	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	14.31	0.40	0.00	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	13.37	0.00	1.22	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	7.61	0.00	0.69	0.00	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	12.92	0.76	0.00	0.00	0.76	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	8.78	0.52	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	6.05	0.00	0.00	0.00	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	15.53	0.95	0.95	0.63	0.32	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	9.06	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	4.02	0.00	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	8.74	1.03	0.51	0.00	1.03	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	9.20	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	10.21	0.00	0.57	0.57	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	9.98	0.83	1.25	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	7.05	0.00	0.00	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	5.85	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	8.36	0.00	0.00	0.00	0.00	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	9.37	0.00	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	8.02	0.00	0.00	0.00	0.00	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	12.12	0.00	0.00	0.00	0.81	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	5.51	0.92	0.92	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	3.56	0.00	0.00	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	13.11	0.00	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	8.44	0.77	1.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	7.66	0.55	0.00	0.55	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	12.03	0.00	0.00	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	17.16	0.26	0.52	0.26	0.26	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	12.60	0.00	0.00	0.00	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	16.63	0.00	0.00	0.00	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	41.48	0.46	0.46	0.46	0.00	0.46
Macrophage - monocyte derived, donor2	11313-117C8	35.78	0.37	0.55	0.73	0.73	0.00
Macrophage - monocyte derived, donor3	11389-118C3	41.55	0.39	0.26	0.39	0.39	0.66
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	30.80	0.53	1.59	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	40.41	0.32	0.48	0.16	0.32	0.16
Mallassez-derived cells, donor3	11930-125I4	41.70	0.56	1.25	0.28	0.14	0.14
Mammary Epithelial Cell, donor1	11273-116H4	42.35	0.30	0.90	1.00	0.80	0.60
Mammary Epithelial Cell, donor2	11350-117G9	31.85	0.29	1.16	0.58	0.29	0.29
Mammary Epithelial Cell, donor3	11422-118F9	20.45	0.00	0.25	0.25	1.00	0.25
Mast cell - stimulated, donor1	11487-119E2	125.42	0.68	0.68	0.00	1.36	0.00
Mast cell, donor1	11563-120D6	31.47	0.65	0.43	0.65	2.49	0.54
Mast cell, donor2	11565-120D8	30.91	0.00	0.00	2.38	2.67	0.00
Mast cell, donor3	11566-120D9	40.75	0.00	0.00	2.70	3.15	0.23
Mast cell, donor4	11567-120E1	28.72	0.18	0.00	1.77	1.60	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	34.82	1.00	0.11	2.33	0.55	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	28.02	0.00	0.00	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	26.84	0.11	0.23	1.03	0.92	0.57
Mast cell, expanded, donor8	11941-126A6	28.62	0.17	0.67	1.17	0.84	0.33
Melanocyte - dark, donor1	11502-119F8	31.64	0.30	0.40	0.40	0.90	0.20
Melanocyte - dark, donor2	11582-120F7	20.07	0.69	0.69	0.00	0.35	0.35
Melanocyte - dark, donor3	11663-122F7	28.18	0.36	0.65	0.36	1.16	0.14
Melanocyte - light, donor1	11274-116H5	8.23	0.00	0.24	0.24	0.00	0.00
Melanocyte - light, donor2	11351-117H1	8.87	0.00	0.00	0.00	1.36	0.68
Melanocyte - light, donor3	11423-118G1	6.07	0.87	0.87	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	16.97	0.52	0.73	0.52	0.31	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	21.78	0.27	0.54	0.27	0.27	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	24.37	0.80	0.27	0.00	0.80	0.00
Meningeal Cells, donor1	11493-119E8	24.07	0.12	0.50	0.50	0.12	0.12
Meningeal Cells, donor2	11573-120E7	24.65	0.00	0.88	0.44	0.88	0.00
Meningeal Cells, donor3	11654-122E7	50.78	0.82	1.47	1.06	0.65	0.33
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	49.05	0.00	0.86	0.57	1.14	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	32.50	0.20	0.91	0.40	0.20	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	7.88	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	7.85	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	26.55	0.72	0.00	0.72	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	36.00	0.42	0.64	0.85	1.06	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	37.20	0.50	1.01	0.00	0.50	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	14.94	0.22	0.22	0.44	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	10.96	0.73	0.00	0.00	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	10.43	0.00	0.20	0.41	0.20	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	40.31	0.14	0.14	0.14	0.14	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	10.04	0.00	0.00	0.37	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	60.26	1.18	0.66	0.79	0.53	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	7.42	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	12.17	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	42.18	0.00	1.42	0.35	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	50.04	0.63	0.63	0.63	1.25	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	21.77	0.00	0.73	0.00	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	30.76	0.53	0.80	0.27	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	23.52	0.00	1.00	0.00	0.50	0.50
Mesothelial Cells, donor3	11402-118D7	22.26	1.16	0.65	0.22	0.29	0.94
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	58.06	0.00	0.00	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	32.26	0.25	0.00	0.25	0.49	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	40.34	0.29	1.77	0.29	0.29	1.18
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	41.48	0.00	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	20.15	0.31	0.62	0.62	0.31	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	29.04	1.04	1.45	0.21	0.41	1.04
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	39.37	0.00	0.00	0.00	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	29.78	0.50	1.00	0.50	1.00	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	30.26	0.00	1.86	0.47	0.93	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	23.37	0.41	0.41	0.20	0.20	0.81
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	29.70	0.79	0.00	0.40	0.40	1.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	59.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	19.47	0.00	1.77	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	30.77	0.76	0.00	0.38	0.38	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	26.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	16.77	1.49	0.64	0.64	0.00	1.06
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	17.50	0.00	0.00	0.92	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	18.18	0.89	0.00	0.89	0.30	0.89
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	20.12	0.00	0.00	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	21.08	1.00	0.00	0.50	0.00	1.51
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	31.13	0.71	0.71	0.00	1.66	1.43
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	40.36	0.00	0.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	17.27	0.46	0.23	0.23	0.00	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	27.34	0.84	0.21	0.42	0.84	1.05
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	20.59	0.00	0.61	0.00	0.41	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	22.10	0.64	0.21	0.43	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	33.12	0.44	0.44	0.22	0.44	0.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	51.59	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	17.52	0.22	0.44	0.00	0.44	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	32.95	0.51	1.01	0.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	48.05	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	24.73	1.09	0.82	0.54	0.27	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	26.76	0.29	0.88	0.00	0.00	1.18
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	37.07	0.00	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	14.90	0.48	0.00	0.00	0.00	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	29.22	1.60	0.40	0.40	2.00	2.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	27.42	0.00	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	21.52	0.00	0.50	0.00	0.50	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	16.31	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	21.90	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	27.59	0.00	0.00	2.21	0.00	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	28.18	0.00	0.64	0.64	3.20	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	19.59	0.50	0.00	0.25	0.25	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	24.36	0.00	0.00	0.70	0.70	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	39.78	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	21.20	0.68	0.34	0.68	0.34	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	21.44	0.00	0.88	0.44	2.19	1.31
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	23.44	0.00	0.00	0.71	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	24.41	0.56	0.00	0.28	0.00	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	25.77	1.25	0.00	0.83	0.83	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	27.97	0.00	0.00	0.00	1.17	1.17
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	18.40	0.90	0.00	0.60	0.00	0.90
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	27.97	0.42	1.25	0.42	0.83	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	0.00	0.00	7.22	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	24.01	0.92	2.77	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	32.44	0.00	1.14	0.57	0.57	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	26.25	0.69	0.28	0.97	0.14	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	21.25	0.26	0.52	0.26	0.26	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	28.74	1.72	1.72	1.29	2.57	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	24.14	0.00	0.64	1.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	25.62	0.53	0.80	0.00	0.27	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	35.02	0.30	1.20	0.60	0.30	1.50
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	24.44	0.71	0.28	0.85	0.14	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	16.24	0.32	0.32	0.64	0.00	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	34.72	1.33	0.88	1.77	0.88	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	25.41	0.38	0.38	0.38	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	24.15	0.28	0.85	1.42	0.00	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	26.55	0.98	1.47	0.74	0.74	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	28.02	0.00	0.00	1.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	25.29	0.88	0.59	0.00	0.29	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	29.41	1.15	0.86	0.29	0.58	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	63.06	1.24	0.82	0.41	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	30.67	0.30	1.19	0.60	0.00	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	10.69	0.00	0.00	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	19.06	0.33	0.66	0.00	0.00	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	6.31	0.00	0.00	0.00	1.05	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	22.54	0.00	0.00	0.20	0.79	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	13.04	0.00	0.00	0.93	0.00	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	14.65	1.13	0.00	0.00	0.38	1.88
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	17.84	0.27	0.00	0.27	0.00	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	24.20	0.23	0.00	0.90	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	13.26	0.00	0.00	1.47	0.00	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	15.02	0.37	1.47	0.73	0.37	1.83
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	24.89	6.22	0.00	0.00	0.00	6.22
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	20.84	0.00	0.53	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	11.59	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	15.15	0.00	2.02	2.02	0.00	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	16.44	0.42	0.42	0.84	0.84	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	12.26	0.00	0.00	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	5.72	0.00	0.00	0.00	1.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	7.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	51.39	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	29.36	0.00	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	45.03	0.22	0.43	1.08	0.22	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	40.76	0.00	0.00	1.05	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	14.68	0.67	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	15.03	0.00	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	23.20	0.19	0.19	0.76	0.38	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	20.75	0.00	0.00	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	6.12	0.00	0.00	0.00	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	93.72	3.68	0.00	0.00	1.84	5.51
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	16.74	0.42	0.00	0.00	0.00	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	17.67	0.00	0.23	0.23	0.46	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	14.32	0.00	0.54	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	26.91	0.63	0.00	0.42	0.21	1.26
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	367.45	0.00	0.00	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	14.39	0.50	0.99	0.99	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	19.49	0.00	0.00	0.27	0.27	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	18.13	0.00	0.00	0.23	0.23	1.13
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	15.02	0.00	0.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	28.98	0.91	0.00	0.18	0.73	0.91
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	15.38	0.00	0.00	1.06	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	12.01	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	28.22	0.00	0.66	0.33	0.66	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	13.82	0.16	0.16	0.33	0.81	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	29.46	0.71	0.53	0.35	0.35	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	8.44	0.00	0.70	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	17.47	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	18.00	0.00	0.32	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	21.04	0.69	0.00	1.03	1.38	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	126.42	0.00	2.53	2.53	5.06	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	31.64	0.45	0.45	0.22	0.45	0.89
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	17.78	0.00	1.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	18.28	0.24	0.24	0.00	0.00	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	21.46	0.00	0.00	0.00	1.72	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	243.75	9.03	0.00	0.00	18.06	18.06
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	13.00	0.00	0.00	0.00	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	23.90	0.00	0.90	0.00	0.45	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	13.09	0.00	0.00	0.40	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	18.57	0.00	0.00	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	15.89	0.00	0.00	0.00	0.76	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	14.01	0.33	0.00	0.33	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	12.64	0.00	0.44	0.44	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	29.40	0.90	0.45	0.00	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	11.46	0.00	0.00	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	21.28	0.00	0.00	0.00	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	15.87	0.00	0.50	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	11.87	0.00	0.38	0.00	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	26.31	0.00	0.00	0.30	0.30	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	25.86	1.55	0.88	0.44	0.44	1.33
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	9.49	0.00	0.00	0.00	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	137.96	0.00	0.00	5.11	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	10.36	0.00	0.00	0.00	0.61	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	16.05	0.00	0.00	0.00	0.31	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	9.68	0.30	0.00	0.00	0.30	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	14.24	0.00	0.00	0.00	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	38.54	2.27	0.00	0.00	1.13	3.40
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	141.62	10.12	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	42.11	0.99	1.24	0.25	0.00	0.25
Myoblast, donor2	11322-117D8	35.48	1.15	0.19	0.58	0.77	0.96
Myoblast, donor3	11398-118D3	51.79	0.34	1.01	1.35	1.35	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	55.45	1.75	0.58	0.44	0.58	2.19
Natural Killer Cells, donor1	11230-116C6	34.13	0.62	0.00	2.77	1.23	0.00
Natural Killer Cells, donor2	11311-117C6	29.25	1.81	0.00	1.21	0.30	0.90
Natural Killer Cells, donor3	11387-118C1	28.90	1.29	0.00	0.92	1.47	0.74
Neural stem cells, donor1	11275-116H6	53.72	0.00	0.36	0.36	0.00	0.73
Neural stem cells, donor2	11352-117H2	61.62	1.93	0.00	0.00	3.85	3.85
Neurons, donor1	11494-119E9	15.93	0.00	0.00	0.00	0.00	0.00
Neurons, donor2	11574-120E8	42.93	0.22	0.44	0.88	0.00	0.66
Neurons, donor3	11655-122E8	19.73	0.82	1.64	0.82	0.00	0.82
Neutrophils, donor1	11233-116C9	208.80	5.57	5.57	6.50	3.71	2.78
Neutrophils, donor2	11314-117C9	110.16	8.70	0.00	2.90	0.00	5.80
Neutrophils, donor3	11390-118C4	312.14	2.44	2.44	3.67	3.67	1.83
Nucleus Pulposus Cell, donor1	11252-116F1	54.38	0.59	0.36	0.95	0.24	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	29.96	0.00	0.00	0.00	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	19.85	0.20	0.20	0.40	0.80	0.00
Olfactory epithelial cells, donor1	11933-125I7	19.96	0.41	0.14	0.28	0.28	1.24
Olfactory epithelial cells, donor2	11934-125I8	29.96	1.88	0.43	0.14	0.58	1.16
Olfactory epithelial cells, donor3	11935-125I9	30.76	0.68	0.45	0.34	0.11	0.68
Olfactory epithelial cells, donor4	11936-126A1	27.08	0.58	0.10	0.19	0.19	0.78
Oligodendrocyte - precursors, donor1	11496-119F2	48.15	0.00	1.20	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	41.26	0.00	0.43	1.28	0.00	0.21
Osteoblast - differentiated, donor2	11353-117H3	11.43	0.00	1.14	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	15.52	0.00	0.62	0.62	0.62	0.00
Osteoblast, donor1	11277-116H8	30.49	0.00	0.39	0.98	0.00	0.00
Osteoblast, donor2	11354-117H4	38.63	0.70	1.40	0.70	0.70	0.00
Osteoblast, donor3	11426-118G4	44.79	0.53	0.71	0.18	0.36	0.71
Pancreatic stromal cells, donor1	11249-116E7	63.51	0.93	0.93	0.84	0.42	0.59
Pericytes, donor1	11491-119E6	5.34	0.11	0.22	0.00	0.11	0.00
Pericytes, donor2	11571-120E5	7.24	0.00	0.00	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	8.54	0.20	0.20	0.00	0.00	0.20
Perineurial Cells, donor1	11499-119F5	50.07	0.45	0.45	0.68	0.90	0.00
Perineurial Cells, donor2	11579-120F4	45.73	0.28	1.20	0.55	1.56	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	60.88	0.64	0.00	0.96	0.96	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	28.65	0.73	0.49	0.49	0.73	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	32.87	0.91	0.13	1.68	1.29	0.13
Placental Epithelial Cells, donor1	11278-116H9	9.33	0.00	0.48	0.24	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	7.76	1.11	0.00	1.11	0.00	2.22
Placental Epithelial Cells, donor3	11427-118G5	8.64	0.59	0.20	0.20	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	12.34	0.95	0.63	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	36.20	0.38	0.75	0.56	0.19	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	74.66	0.65	1.57	1.44	1.17	0.52
Preadipocyte - breast, donor2	11328-117E5	33.10	1.80	0.90	0.68	0.90	0.90
Preadipocyte - omental, donor1	11468-119C1	42.62	0.43	0.53	0.53	0.32	0.43
Preadipocyte - omental, donor2	11329-117E6	41.90	0.44	0.87	0.00	0.00	1.31
Preadipocyte - omental, donor3	11403-118D8	39.97	0.72	0.29	0.43	1.58	0.86
Preadipocyte - perirenal, donor1	11469-119C2	9.84	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	19.96	0.00	0.61	0.31	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	56.31	1.77	1.95	1.06	0.71	0.89
Preadipocyte - subcutaneous, donor3	11428-118G6	37.12	0.51	0.68	0.17	1.02	1.02
Preadipocyte - visceral, donor1	11280-116I2	58.87	0.47	1.86	0.93	0.93	0.65
Preadipocyte - visceral, donor2	11357-117H7	44.18	2.30	0.46	0.00	0.92	0.92
Preadipocyte - visceral, donor3	11429-118G7	29.88	0.94	0.52	0.63	0.73	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	39.37	0.30	0.91	0.15	0.60	0.45
Prostate Epithelial Cells, donor2	11331-117E8	19.63	0.54	0.68	0.14	0.14	0.27
Prostate Epithelial Cells, donor3	11404-118D9	24.56	1.35	0.00	0.61	0.49	0.92
Prostate Stromal Cells, donor1	11254-116F3	52.62	0.68	1.59	0.34	0.34	0.11
Prostate Stromal Cells, donor2	11332-117E9	36.58	2.51	0.36	0.54	0.72	1.61
Prostate Stromal Cells, donor3	11405-118E1	29.82	1.15	0.10	0.52	0.83	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	13.50	0.00	0.00	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	37.77	0.35	0.28	0.21	0.14	0.35
Renal Epithelial Cells, donor1	11517-119H5	9.13	0.51	0.51	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	8.54	1.42	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	44.15	0.74	0.11	0.32	0.42	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	2.04	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	6.87	0.40	0.40	0.13	0.00	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	30.42	1.55	0.67	0.89	0.22	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	3.99	0.00	0.00	0.00	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	10.78	0.44	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	10.03	0.63	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	6.66	0.55	0.00	0.28	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	15.57	0.00	0.00	0.00	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	8.43	0.00	0.00	0.42	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	12.73	0.19	0.39	0.00	0.19	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	43.56	0.00	0.26	2.33	0.52	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	9.10	0.28	0.00	0.00	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	8.23	0.00	0.00	0.00	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	30.86	0.25	0.25	0.25	0.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	67.89	1.20	0.40	0.80	0.40	0.80
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	58.96	0.00	0.00	2.68	0.89	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	35.77	3.85	1.10	1.65	0.00	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	100.93	4.06	0.58	2.32	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	104.80	1.69	2.86	1.95	0.52	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	90.07	2.28	1.89	1.09	0.20	2.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	130.61	0.78	2.45	1.00	0.45	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	104.57	4.09	2.98	1.86	1.61	3.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	86.13	4.43	2.45	1.17	0.70	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	110.25	2.77	3.24	2.08	0.23	2.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	64.21	1.78	1.23	0.68	0.82	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	98.48	2.72	1.97	1.21	0.61	3.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	119.34	0.72	3.40	1.25	0.36	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	63.55	2.58	1.29	1.43	1.29	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	86.17	1.72	1.61	0.86	0.21	1.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	82.98	1.11	2.88	1.33	0.66	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	71.31	1.15	1.91	0.96	0.57	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	91.11	1.68	2.52	0.37	0.37	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	147.13	1.50	3.76	1.13	0.00	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	71.00	1.19	1.73	1.06	1.33	2.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	98.61	3.60	3.21	1.07	0.58	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	92.23	1.72	0.95	0.76	0.00	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	60.34	1.07	1.92	0.96	1.17	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	91.38	3.08	3.08	1.40	0.00	3.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	99.63	1.71	2.73	0.85	0.68	2.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	58.89	1.46	2.37	1.28	0.55	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	78.61	2.82	1.72	0.86	0.49	1.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	97.52	1.34	3.49	1.48	0.67	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	57.08	1.18	2.12	0.24	0.47	1.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	91.87	3.77	2.78	0.79	0.20	2.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	100.32	0.00	2.34	1.40	0.23	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	61.79	2.49	1.45	0.83	1.66	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	87.60	5.09	1.99	0.88	0.22	2.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	90.86	1.04	1.67	1.25	0.63	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	66.22	1.21	2.15	0.94	1.08	2.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	106.43	1.53	2.21	2.38	0.68	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	98.33	0.96	2.51	1.16	0.19	1.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	63.79	2.75	1.55	1.72	0.69	1.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	92.18	1.23	2.33	1.92	0.55	1.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	95.71	1.81	4.43	1.15	0.33	2.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	67.15	1.70	1.53	1.53	0.68	1.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	119.25	1.33	2.07	1.04	0.74	2.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	92.49	1.87	2.13	1.33	1.60	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	49.22	0.41	0.97	1.38	0.97	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	80.95	1.90	1.43	1.90	0.71	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	110.85	1.21	3.02	0.81	2.22	2.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	51.98	0.85	1.79	1.60	0.75	1.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	79.31	0.70	1.05	0.00	0.70	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	62.86	0.30	2.12	1.21	1.21	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	52.38	1.84	2.20	1.22	1.47	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	178.30	1.16	4.22	1.75	0.44	1.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	65.10	1.83	3.04	0.61	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	48.22	0.30	2.41	1.21	0.00	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	68.99	1.58	1.81	0.90	0.45	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	79.38	0.30	1.20	0.60	0.60	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	60.45	1.18	2.24	2.72	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	72.57	1.49	0.85	1.07	0.64	1.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	69.71	1.20	1.80	0.00	1.20	1.20
Schwann Cells, donor1	11498-119F4	6.77	0.38	0.38	0.38	0.19	0.00
Schwann Cells, donor2	11578-120F3	6.80	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	19.94	0.88	0.00	0.44	0.66	0.88
Sebocyte, donor1	11220-116B5	44.37	0.55	0.55	0.00	0.55	0.00
Sebocyte, donor2	11301-117B5	26.65	0.46	1.38	0.00	0.00	0.46
Sebocyte, donor3	11378-118B1	15.25	0.41	0.00	0.21	0.21	0.00
Sertoli Cells, donor1	11255-116F4	49.70	0.00	1.66	1.66	0.00	0.00
Sertoli Cells, donor2	11333-117F1	31.07	2.82	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	31.85	0.26	0.18	0.70	0.35	0.44
Skeletal Muscle Cells, donor2	11358-117H8	7.95	0.00	0.00	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	19.23	0.00	0.00	0.84	2.51	0.00
Skeletal Muscle Cells, donor4	11451-119A2	36.60	0.31	0.47	0.79	0.16	0.79
Skeletal Muscle Cells, donor5	11455-119A6	36.86	1.49	0.89	1.04	0.30	0.59
Skeletal Muscle Cells, donor6	11459-119B1	37.24	0.77	1.39	0.46	0.62	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	93.12	0.50	1.13	0.88	1.01	0.63
Skeletal Muscle Satellite Cells, donor2	11321-117D7	68.92	1.85	0.86	0.86	1.57	1.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	59.33	2.08	0.99	0.10	1.39	1.09
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	43.31	0.59	0.42	0.59	0.42	0.59
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	16.65	0.72	0.72	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	11.83	0.28	0.28	0.28	0.14	0.41
Skin - palm, donor1	10286-104F7	18.80	0.00	0.00	0.00	0.00	8.06
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	7.78	0.00	0.14	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	36.81	0.82	2.45	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	8.31	0.13	0.52	0.13	0.00	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	40.73	0.83	1.39	0.28	0.42	0.56
Small Airway Epithelial Cells, donor2	11334-117F2	30.38	0.98	0.56	0.56	0.98	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	158.58	0.63	5.50	1.48	1.48	1.27
Small Airway Epithelial Cells, donor3	11406-118E2	38.67	0.75	0.45	0.45	0.15	0.97
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	13.89	0.31	0.93	0.00	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	34.46	0.44	2.00	0.67	0.22	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	41.15	0.00	0.00	0.00	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	16.13	0.22	0.22	0.22	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	19.69	1.18	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	33.22	0.00	1.55	1.55	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	38.03	1.00	1.00	1.00	2.00	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	30.47	0.67	0.40	1.46	0.27	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	30.81	0.44	0.66	0.00	1.11	1.11
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	37.13	1.02	0.90	0.38	0.38	0.51
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	47.86	0.65	1.95	0.33	0.33	0.98
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	45.18	0.30	1.18	0.30	2.07	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	37.58	0.71	1.42	0.43	1.28	0.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	7.81	0.00	0.16	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	24.05	0.91	0.30	0.30	1.22	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	27.53	0.25	0.76	0.76	0.51	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	10.01	0.48	0.00	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	54.42	0.44	1.47	0.15	0.15	0.74
Smooth Muscle Cells - Colonic, donor2	11320-117D6	34.22	2.15	1.29	0.22	0.22	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	51.01	1.05	1.15	0.73	0.73	0.52
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	23.51	0.46	1.08	0.62	0.15	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	12.93	0.00	1.08	0.00	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	11.95	0.30	0.30	0.60	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	11.27	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	82.85	0.86	0.79	0.24	1.02	0.39
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	57.16	1.41	1.11	1.11	0.60	0.40
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	24.35	0.91	0.46	0.23	0.00	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	8.45	0.00	0.00	0.60	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	56.43	1.32	1.32	1.06	1.32	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	39.28	0.27	0.93	1.73	1.07	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	41.70	1.00	0.75	0.50	0.88	1.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	31.20	0.00	0.76	0.25	0.25	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	33.77	0.00	0.30	0.60	0.30	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	25.51	0.00	0.00	0.00	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	14.21	0.00	0.00	0.00	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	27.44	0.00	0.00	0.00	0.47	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	20.70	1.01	1.51	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	16.61	0.63	0.94	0.94	0.63	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	8.26	0.29	0.00	0.29	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	65.06	0.17	1.50	0.67	2.92	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	30.37	1.40	0.00	0.00	0.93	1.40
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	29.36	0.14	0.43	0.29	0.00	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	26.26	0.00	0.00	0.51	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	12.97	0.19	0.19	0.19	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	45.70	0.28	0.70	0.70	1.54	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	39.72	0.25	0.50	0.17	0.92	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	3.33	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	27.16	0.24	1.71	0.73	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	30.71	1.77	1.33	1.33	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	28.97	0.29	0.88	1.17	0.88	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	25.27	0.58	0.19	0.00	0.00	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	22.21	1.06	0.53	0.26	0.00	1.06
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	18.23	0.37	0.00	1.12	0.00	1.49
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	31.26	0.72	0.72	0.72	0.00	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	31.80	0.57	0.85	0.28	0.00	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	24.42	0.39	0.39	0.00	0.39	1.18
Smooth muscle cells - airway, control, donor1	11966-126D4	20.32	0.76	0.25	0.00	0.25	1.02
Smooth muscle cells - airway, control, donor2	11967-126D5	16.77	1.20	0.00	0.40	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	16.72	0.00	0.00	1.67	0.00	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	16.04	0.46	0.00	0.92	0.00	0.46
Synoviocyte, donor1	11291-117A4	31.98	0.50	0.67	0.17	0.17	0.50
Synoviocyte, donor2	11368-117I9	24.31	0.67	0.00	0.50	0.00	0.34
Synoviocyte, donor3	11440-118H9	16.53	1.56	0.22	0.67	0.67	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	16.79	0.00	0.36	0.36	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	9.91	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	12.27	0.00	0.23	0.69	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	29.46	0.29	0.86	0.57	0.14	0.50
Tracheal Epithelial Cells, donor2	11369-118A1	8.50	0.00	0.39	0.39	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	5.73	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	58.19	1.23	0.37	0.98	0.98	0.37
Urethra, donor2	10319-105A4	28.77	0.00	0.00	1.80	0.00	14.39
Urothelial Cells, donor1	11520-119H8	4.78	0.00	0.00	0.00	0.00	0.27
Urothelial Cells, donor2	11600-120H7	5.61	0.00	0.00	0.80	0.00	0.00
Urothelial Cells, donor3	11681-122H7	2.06	0.00	0.00	0.23	0.00	0.46
Urothelial cells, donor0	11216-116B1	37.00	0.00	0.00	0.67	0.22	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	84.53	0.89	2.67	3.56	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	85.78	0.00	1.43	7.15	0.00	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	82.83	2.05	1.37	4.79	0.00	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	85.74	0.00	1.03	3.79	0.69	2.07
Whole blood (ribopure), donor090325, donation2	12177-128I8	82.51	0.00	0.58	3.49	0.00	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	87.46	2.08	2.08	7.29	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	78.01	1.84	0.92	3.67	0.92	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	67.55	1.83	0.91	3.65	0.00	2.74
Wilms' tumor cell line:G-401	10809-111A8	43.79	0.62	1.60	0.37	1.23	0.99
Wilms' tumor cell line:HFWT	10597-108E3	25.52	0.00	0.00	0.00	0.88	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	28.49	0.56	0.56	0.56	0.28	0.56
achilles tendon, donor2	10292-104G4	12.40	2.07	2.07	0.00	0.00	4.13
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	61.44	1.02	1.78	1.78	2.04	1.27
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	60.83	0.23	0.23	2.32	1.86	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	81.55	1.19	0.71	2.02	0.59	0.95
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	64.22	0.82	0.54	1.09	2.18	1.36
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	48.35	3.65	0.56	0.00	0.28	1.41
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	57.95	0.42	2.54	0.63	0.00	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	66.42	1.09	1.63	0.27	0.27	3.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	56.40	1.32	2.20	0.88	1.32	4.41
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	54.72	2.45	0.41	0.00	1.23	2.04
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	35.72	2.72	0.00	0.39	1.16	1.55
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	44.16	0.92	0.55	0.00	0.37	2.21
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	39.01	0.00	0.00	3.90	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	39.97	1.86	1.16	0.70	0.23	1.63
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	54.63	1.55	0.52	0.78	1.29	1.55
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	52.60	2.92	0.88	1.17	0.00	2.05
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	50.19	1.39	0.46	0.93	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	37.84	0.41	0.82	0.82	0.00	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	51.57	0.92	2.76	0.31	0.92	1.84
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	109.24	1.71	3.84	2.56	0.43	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	114.64	0.00	3.94	1.52	0.00	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	119.87	0.72	2.17	0.96	0.00	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	35.19	0.45	1.34	0.89	0.00	0.89
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	54.03	1.33	1.33	0.67	0.00	1.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	79.90	0.00	3.72	3.72	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	190.59	3.39	6.78	0.38	1.13	3.39
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	47.97	0.44	0.87	0.44	0.00	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	78.73	0.00	1.87	0.00	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	55.34	1.18	0.24	0.24	0.94	1.41
adipose tissue, adult, pool1	10010-101C1	46.07	1.09	0.16	1.40	0.31	0.47
adipose, donor1	10184-103D4	68.02	2.93	0.00	1.76	1.17	2.93
adipose, donor2	10185-103D5	14.60	0.00	1.22	0.41	0.41	0.81
adipose, donor3	10186-103D6	24.78	0.82	0.54	0.54	0.27	0.82
adipose, donor4	10187-103D7	28.60	0.87	0.00	0.00	2.60	7.80
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	54.29	0.32	0.00	2.37	0.95	1.26
adrenal gland, adult, pool1	10081-102A9	21.83	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	52.30	0.93	0.40	2.80	0.27	0.67
alveolar cell carcinoma cell line:SW 1573	10708-109H6	39.30	1.07	0.71	1.43	0.36	2.14
amniotic membrane cells, donor1	12235-129G3	36.86	0.46	0.00	0.46	0.70	0.46
amniotic membrane cells, donor2	12236-129G4	30.43	0.68	0.00	1.35	3.72	0.00
amniotic membrane cells, donor3	12237-129G5	32.11	0.88	0.29	3.54	2.06	0.88
amygdala - adult, donor10196	10167-103B5	36.76	1.19	0.00	0.00	0.00	3.56
amygdala, adult, donor10252	10151-102I7	50.08	1.22	0.20	2.84	5.27	3.65
amygdala, newborn, donor10223	10360-105E9	28.73	0.32	0.00	1.29	0.00	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	53.99	0.76	0.38	1.27	1.40	0.51
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	53.61	1.54	1.10	0.66	0.44	1.10
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	67.14	2.67	0.67	1.00	2.67	2.67
aorta, adult, pool1	10052-101G7	19.22	1.57	0.00	0.59	1.18	1.18
appendix, adult	10189-103D9	48.51	0.39	0.39	1.16	0.00	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	46.78	1.72	0.69	0.00	0.34	1.38
artery, adult	10190-103E1	84.24	2.72	1.36	4.08	2.72	0.00
astrocytoma cell line:TM-31	10425-106D2	47.66	0.43	0.29	0.87	0.29	0.58
b cell line:RPMI1788	10427-106D4	63.94	0.74	0.45	1.34	0.59	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	47.17	0.55	0.00	0.28	1.11	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	66.09	0.30	2.08	0.69	0.10	0.50
bile duct carcinoma cell line:TFK-1	10496-107C1	58.92	0.50	0.50	0.00	0.00	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	40.82	1.12	1.12	1.68	0.00	0.00
bladder, adult, pool1	10011-101C2	37.26	0.54	0.22	1.63	0.98	0.33
blood, adult, pool1	10053-101G8	31.00	2.21	0.00	4.43	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	40.25	0.00	0.00	0.00	0.86	0.00
bone marrow, adult	10192-103E3	49.94	0.67	0.67	0.67	0.00	2.02
brain, adult, donor1	10084-102B3	11.28	3.08	0.00	0.00	3.08	3.08
brain, adult, pool1	10012-101C3	33.52	0.56	0.33	3.01	1.22	0.22
brain, fetal, pool1	10085-102B4	29.39	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	34.03	2.97	0.99	0.33	0.33	1.98
breast carcinoma cell line:MDA-MB-453	10419-106C5	62.79	0.12	0.87	1.87	0.62	0.00
breast, adult, donor1	10080-102A8	22.73	1.26	0.00	0.00	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	29.22	0.89	0.64	0.00	0.13	0.89
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	37.42	0.93	1.24	0.93	0.31	1.24
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	17.04	1.15	0.46	0.69	0.00	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	22.51	0.48	0.97	0.48	0.24	0.24
carcinoid cell line:NCI-H1770	10703-109H1	46.08	0.47	0.00	1.41	2.35	2.35
carcinoid cell line:NCI-H727	10735-110B6	47.80	0.66	1.20	0.77	1.20	0.66
carcinoid cell line:SK-PN-DW	10719-109I8	60.53	1.58	0.63	0.32	1.27	3.80
carcinosarcoma cell line:JHUCS-1	10642-109A3	38.60	1.86	0.27	0.53	0.27	1.86
caudate nucleus - adult, donor10196	10177-103C6	34.54	0.00	0.00	1.15	0.00	3.45
caudate nucleus, adult, donor10252	10164-103B2	50.70	2.18	0.00	1.51	3.18	2.51
caudate nucleus, adult, donor10258	10379-105H1	42.79	0.00	2.29	3.82	0.00	1.53
caudate nucleus, newborn, donor10223	10354-105E3	28.93	0.37	0.00	0.37	0.37	0.00
cerebellum - adult, donor10196	10173-103C2	58.27	2.91	0.00	5.83	2.91	2.91
cerebellum, adult, donor10252	10166-103B4	76.22	2.99	0.43	3.42	4.48	1.49
cerebellum, adult, pool1	10083-102B2	24.49	0.69	0.69	1.72	1.72	1.38
cerebellum, newborn, donor10223	10357-105E6	55.63	1.66	1.66	3.32	0.00	2.49
cerebral meninges, adult	10188-103D8	37.82	1.76	0.00	0.25	0.25	0.50
cerebrospinal fluid, donor2	10294-104G6	34.35	2.92	0.73	0.73	0.73	6.58
cervical cancer cell line:D98-AH2	10552-107I3	75.77	0.86	1.01	1.29	1.01	0.00
cervical cancer cell line:ME-180	10553-107I4	44.91	0.17	0.99	0.50	0.83	0.33
cervix, adult, pool1	10013-101C4	46.51	1.05	0.21	1.57	1.36	0.52
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	87.23	0.42	0.56	0.56	0.84	0.98
chondrosarcoma cell line:SW 1353	10700-109G7	47.03	0.00	0.00	1.31	1.31	2.61
choriocarcinoma cell line:BeWo	10423-106C9	72.58	1.37	2.98	1.24	0.37	0.87
choriocarcinoma cell line:SCH	10785-110H2	35.24	1.48	0.99	0.74	0.25	1.23
choriocarcinoma cell line:T3M-3	10618-108G6	34.15	0.24	1.66	1.66	0.95	0.71
chorionic membrane cells, donor1	12238-129G6	17.10	0.57	0.28	1.71	0.57	0.28
chorionic membrane cells, donor2	12239-129G7	49.82	1.09	0.99	0.50	1.49	0.60
chorionic membrane cells, donor3	12240-129G8	23.08	1.10	0.00	1.10	1.10	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	26.25	3.03	1.01	1.01	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	43.61	0.58	1.73	0.58	0.38	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	76.45	0.63	1.69	1.06	0.21	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	104.52	2.05	7.70	0.77	0.77	2.57
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	129.40	2.42	7.98	0.97	1.45	3.87
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	115.85	3.26	8.55	0.20	0.20	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	114.54	1.47	5.30	0.59	0.59	1.47
chronic myelogenous leukemia cell line:KU812	10409-106B4	117.54	0.00	3.39	0.26	0.52	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	41.37	1.60	0.46	1.83	0.46	2.74
clear cell carcinoma cell line:TEN	10636-108I6	39.39	1.21	0.17	0.52	0.35	0.35
colon carcinoma cell line:CACO-2	10513-107D9	41.92	0.18	1.46	0.37	1.28	0.55
colon carcinoma cell line:COLO-320	10420-106C6	52.83	0.00	0.38	0.38	0.76	0.38
colon, adult, donor1	10082-102B1	19.04	0.00	0.00	0.00	1.19	2.38
colon, adult, pool1	10014-101C5	49.47	0.47	0.12	1.41	1.06	0.47
colon, fetal, donor1	10070-101I7	19.78	1.85	0.00	0.62	0.62	1.24
common myeloid progenitor CMP, donor1	12130-128D6	215.43	0.00	4.58	13.75	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	77.34	0.42	1.27	0.85	0.42	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	62.18	1.51	2.41	0.91	0.00	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	60.63	1.27	1.69	0.28	0.14	0.42
corpus callosum, adult, pool1	10042-101F6	46.55	0.66	0.33	3.76	1.22	0.44
cruciate ligament, donor2	10295-104G7	18.64	0.00	0.00	0.00	0.81	5.67
diaphragm, fetal, donor1	10069-101I6	44.94	0.00	0.80	0.00	3.21	0.80
diencephalon, adult	10193-103E4	20.88	1.20	0.00	0.72	0.48	1.20
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	33.98	3.90	0.23	1.38	0.00	2.98
ductal cell carcinoma cell line:KLM-1	10438-106E6	95.65	0.51	1.54	0.77	0.26	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	58.98	0.72	1.20	1.20	0.00	0.72
ductus deferens, adult	10196-103E7	33.89	0.00	0.00	1.99	0.50	2.49
duodenum, fetal, donor1, tech_rep1	10071-101I8	20.16	1.44	0.00	0.00	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	34.58	2.94	0.74	3.68	0.00	2.21
dura mater, adult, donor1	10041-101F5	38.82	0.17	0.17	1.16	0.66	0.33
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	31.09	0.00	1.33	1.11	0.22	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	50.30	0.86	1.15	0.43	0.86	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	31.45	0.00	0.00	1.23	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	22.40	0.61	0.30	0.30	0.61	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	40.75	0.93	0.00	0.62	0.31	0.93
embryonic pancreas cell line:2C6	10603-108E9	34.15	0.00	0.00	0.00	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	89.83	1.01	2.01	1.01	0.34	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	40.78	0.00	0.54	0.91	0.18	0.91
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	30.88	2.25	1.29	0.16	0.16	1.77
epidermoid carcinoma cell line:A431	10426-106D3	93.60	0.56	0.78	0.89	0.33	1.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	72.70	0.22	1.65	1.10	0.44	0.88
epididymis, adult	10197-103E8	42.07	0.63	0.21	0.00	0.63	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	74.33	2.31	2.31	1.42	1.60	1.77
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	60.56	0.39	0.79	0.79	0.39	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	60.02	2.23	1.70	2.88	2.75	2.75
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	67.32	2.17	2.56	1.97	2.76	1.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	65.87	2.13	2.13	1.79	2.69	1.46
esophagus, adult, pool1	10015-101C6	40.35	0.53	0.42	0.96	0.21	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	91.67	0.63	1.25	1.75	0.88	0.38
eye - muscle inferior rectus, donor1	10272-104E2	28.97	4.83	0.00	2.41	0.00	4.83
eye - muscle lateral, donor2	10298-104H1	46.29	2.10	0.00	0.00	0.00	23.15
eye - muscle medial, donor2	10299-104H2	37.21	1.49	0.00	0.00	0.00	5.95
eye - muscle superior, donor2	10297-104G9	26.37	1.15	1.15	2.29	0.00	8.03
eye - vitreous humor, donor1	10268-104D7	11.66	0.00	0.00	0.00	0.00	7.29
eye, fetal, donor1	10054-101G9	28.98	1.78	0.25	0.76	1.27	1.78
fibrosarcoma cell line:HT-1080	10758-110E2	28.47	0.90	0.38	0.38	0.90	0.77
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	49.15	0.95	0.71	0.47	0.00	1.66
frontal lobe, adult, pool1	10040-101F4	58.92	0.75	0.47	2.53	0.94	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	63.65	0.90	1.20	1.20	0.00	1.50
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	106.07	1.01	0.64	2.10	1.83	0.82
gall bladder, adult	10198-103E9	30.90	0.00	0.24	0.48	0.00	0.24
gamma delta positive T cells, donor1	11937-126A2	34.90	0.54	0.00	1.07	1.61	0.00
gamma delta positive T cells, donor2	11938-126A3	30.63	0.00	0.00	1.49	1.12	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	42.88	2.11	0.63	0.63	0.21	2.75
gastric adenocarcinoma cell line:MKN45	10612-108F9	55.51	1.74	0.58	0.00	0.97	1.74
gastric cancer cell line:AZ521	10549-107H9	65.42	0.82	1.97	1.80	0.82	0.33
gastric cancer cell line:GSS	10560-108A2	24.71	0.00	0.00	0.00	0.92	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	44.32	3.20	0.69	0.46	0.69	2.51
giant cell carcinoma cell line:LU65	10487-107B1	44.40	0.57	0.69	0.23	0.00	0.46
giant cell carcinoma cell line:Lu99B	10433-106E1	71.66	0.70	0.28	0.84	0.56	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	49.14	2.49	0.00	0.25	0.50	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	39.16	0.21	0.74	0.63	0.11	0.53
glioblastoma cell line:A172, tech_rep2	10444-106F3	38.62	0.56	1.26	0.84	1.26	0.56
glioblastoma cell line:T98G	10485-107A8	72.07	1.10	0.44	0.88	0.33	0.44
glioma cell line:GI-1	10413-106B8	36.90	0.00	0.88	0.88	0.59	0.29
globus pallidus - adult, donor10196	10175-103C4	21.87	1.46	0.00	0.00	0.00	2.19
globus pallidus, adult, donor10252	10161-103A8	87.39	2.69	0.49	2.20	5.13	2.69
globus pallidus, adult, donor10258	10367-105F7	24.65	0.00	0.00	5.48	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	24.51	0.53	0.00	0.53	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	146.83	0.00	2.45	4.89	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	0.00	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	31.68	0.96	0.96	0.64	0.32	1.92
hIPS +CCl2, biol_rep1	14383-156B9	27.09	0.92	0.92	0.46	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	23.78	0.00	1.37	0.46	0.00	0.91
hIPS +CCl2, biol_rep3	14385-156C2	12.88	0.00	0.64	0.64	0.00	1.93
hIPS, biol_rep1	14380-156B6	8.62	0.00	1.44	0.00	0.00	1.44
hIPS, biol_rep2	14381-156B7	17.15	0.00	1.37	0.00	0.00	0.69
hIPS, biol_rep3	14382-156B8	13.24	0.00	0.00	2.21	0.00	3.31
hairy cell leukemia cell line:Mo	10712-109I1	22.41	0.57	0.86	1.15	1.44	0.29
heart - mitral valve, adult	10205-103F7	45.44	0.90	0.30	2.39	0.60	1.79
heart - pulmonic valve, adult	10206-103F8	57.52	1.57	0.26	2.35	1.31	0.78
heart - tricuspid valve, adult	10207-103F9	72.44	2.50	0.83	0.00	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	30.00	2.86	0.41	1.22	1.43	1.84
heart, adult, diseased, donor1	10051-101G6	43.01	3.41	0.00	1.70	1.28	5.96
heart, adult, pool1	10016-101C7	76.81	0.46	0.46	2.53	1.84	0.46
heart, fetal, pool1	10046-101G1	85.94	0.31	0.72	2.16	1.64	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	38.87	0.62	0.31	0.31	0.31	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	123.67	1.19	2.38	2.38	1.19	3.57
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	47.18	1.77	1.66	0.33	1.77	0.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	48.91	1.21	1.58	0.36	1.94	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	53.76	1.11	1.21	0.71	1.92	1.31
hepatoma cell line:Li-7	10484-107A7	54.05	0.67	0.89	0.22	0.00	0.44
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	45.12	1.11	0.60	1.31	0.90	0.80
hippocampus - adult, donor10196	10169-103B7	26.50	0.00	0.00	1.89	0.95	1.89
hippocampus, adult, donor10252	10153-102I9	58.58	0.61	1.02	1.63	4.49	4.29
hippocampus, adult, donor10258	10374-105G5	21.41	1.99	0.00	6.47	0.00	1.00
hippocampus, newborn, donor10223	10363-105F3	23.97	0.35	0.00	0.70	0.00	1.41
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	48.22	1.22	1.22	1.83	1.83	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	44.57	0.79	0.98	0.79	0.59	0.98
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	41.64	0.51	1.27	0.51	0.25	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	26.50	1.13	0.56	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	26.08	3.10	0.26	0.26	1.55	2.84
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	35.68	0.38	0.38	1.14	0.38	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	34.45	0.58	0.58	0.88	0.58	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	21.54	0.65	0.65	0.86	0.43	0.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	25.02	0.00	0.42	0.83	0.42	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	41.20	0.47	0.24	1.42	0.95	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	31.98	0.16	0.96	0.32	0.96	0.80
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	28.28	0.00	0.00	0.67	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	50.70	1.88	1.72	0.31	0.63	1.10
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	43.73	1.97	2.46	0.98	0.98	2.46
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	65.46	0.87	1.75	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	31.31	0.19	0.95	0.38	0.38	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	27.91	0.87	0.00	0.44	0.44	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	27.49	0.50	1.00	1.00	1.00	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	19.59	0.38	0.38	1.13	0.75	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	20.01	0.00	0.45	0.45	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	13.16	0.00	0.63	0.94	0.31	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	24.82	0.49	0.65	0.65	0.49	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	17.71	0.58	0.58	0.29	0.58	1.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	24.51	0.30	1.20	0.90	0.60	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	46.56	0.55	0.92	0.18	1.11	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	38.51	0.00	1.43	0.29	0.29	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	44.91	0.00	0.82	1.22	0.82	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	27.81	0.35	1.06	0.35	0.35	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	20.59	0.32	0.00	0.63	0.63	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	30.56	0.61	0.00	0.61	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	17.58	0.00	0.52	0.52	1.55	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	17.27	0.00	1.33	0.66	0.66	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	27.45	0.26	1.80	0.51	0.51	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	24.80	0.26	0.26	0.26	0.77	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	25.75	0.00	0.76	0.76	0.00	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	21.17	0.67	0.67	0.67	0.34	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	42.99	1.21	1.45	0.97	0.24	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	43.67	1.34	0.45	0.89	0.45	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	40.00	0.49	2.44	0.98	0.49	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	26.89	0.92	0.92	0.31	0.61	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	175.68	6.51	0.00	6.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	37.07	0.66	0.66	1.32	0.00	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	24.08	0.00	0.00	1.64	0.55	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	24.25	0.72	0.36	0.36	0.00	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	27.40	0.71	0.71	1.07	0.36	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	27.45	0.00	1.19	0.00	1.19	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	44.42	0.68	1.63	0.41	0.95	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	20.20	0.00	0.81	0.00	0.00	0.00
immature langerhans cells, donor1	11904-125F5	31.24	0.48	1.45	0.48	0.48	0.00
immature langerhans cells, donor2	11905-125F6	18.22	0.00	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	61.13	0.66	0.57	2.84	1.70	0.95
keratoacanthoma cell line:HKA-1	10791-110H8	21.78	0.33	0.65	0.00	0.65	0.33
kidney, adult, pool1	10017-101C8	40.65	0.30	0.80	0.70	0.50	0.60
kidney, fetal, pool1	10045-101F9	34.02	0.50	0.42	1.20	0.78	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	149.55	1.70	2.56	2.13	1.14	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	29.86	1.24	1.11	0.00	0.14	0.69
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	67.34	1.10	1.10	1.65	0.00	0.73
left atrium, adult, donor1	10079-102A7	10.90	3.81	0.00	0.54	1.63	4.90
left ventricle, adult, donor1	10078-102A6	32.36	3.03	0.00	1.01	1.52	0.51
leiomyoblastoma cell line:G-402	10721-110A1	38.85	0.82	1.09	0.55	1.37	1.09
leiomyoma cell line:10964C	10569-108B2	26.94	0.36	0.72	0.72	0.36	1.08
leiomyoma cell line:15242A	10570-108B3	18.48	0.00	0.00	0.54	0.54	1.09
leiomyoma cell line:15425	10571-108B4	24.52	1.46	0.49	0.24	0.24	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	38.10	0.00	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	33.46	1.05	1.05	1.05	0.00	4.18
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	118.88	2.24	2.24	0.35	1.18	1.53
liposarcoma cell line:KMLS-1	10782-110G8	28.59	0.62	0.47	0.78	0.16	0.31
liposarcoma cell line:SW 872	10726-110A6	34.72	0.24	0.73	0.24	0.49	0.73
liver, adult, pool1	10018-101C9	70.17	0.81	1.13	0.32	0.32	0.32
liver, fetal, pool1	10086-102B5	17.87	0.00	0.00	0.00	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	46.52	1.17	0.15	2.92	0.29	2.77
locus coeruleus, adult, donor10252	10165-103B3	57.21	1.48	1.11	2.21	5.91	4.06
locus coeruleus, adult, donor10258	10375-105G6	17.77	0.85	0.00	1.13	0.85	0.56
locus coeruleus, newborn, donor10223	10362-105F2	34.49	1.26	0.42	1.68	0.00	1.68
lung adenocarcinoma cell line:A549	10499-107C4	38.89	0.14	0.42	0.69	0.55	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	76.52	1.38	0.69	3.45	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	30.05	0.13	0.26	0.66	1.05	0.66
lung, adult, pool1	10019-101D1	39.69	0.71	0.00	0.59	1.89	0.59
lung, fetal, donor1	10068-101I5	80.48	0.57	1.71	5.14	0.29	0.00
lung, right lower lobe, adult, donor1	10075-102A3	23.83	2.75	0.00	0.92	0.46	0.46
lymph node, adult, donor1	10077-102A5	22.25	1.89	0.95	0.47	0.95	1.89
lymphangiectasia cell line:DS-1	10727-110A7	53.26	0.22	0.66	0.88	0.00	0.66
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	51.01	0.75	1.66	0.60	0.45	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	67.96	0.00	0.00	1.70	0.00	0.00
mature adipocyte, donor1	12231-129F8	60.83	0.00	0.44	0.89	2.66	0.00
mature adipocyte, donor2	12232-129F9	51.05	0.00	0.21	0.42	0.00	0.00
mature adipocyte, donor3	12233-129G1	55.95	0.00	0.00	1.42	0.47	0.47
mature adipocyte, donor4	12234-129G2	76.33	0.53	0.26	0.53	2.63	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	118.89	1.19	1.67	3.57	2.14	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	41.74	1.13	1.13	1.13	2.26	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	68.41	2.02	0.37	1.10	3.68	2.57
medial frontal gyrus, adult, donor10258	10368-105F8	20.33	1.27	0.00	0.64	0.32	2.22
medial frontal gyrus, newborn, donor10223	10352-105E1	39.66	2.56	0.00	2.56	0.00	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	49.44	9.45	1.35	2.36	0.34	3.38
medial temporal gyrus, adult, donor10252	10156-103A3	64.52	2.55	1.06	1.91	4.67	3.82
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	11.56	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	258.37	28.71	14.35	28.71	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	25.13	0.00	0.00	0.36	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	23.36	1.30	0.00	0.65	0.00	1.30
medulla oblongata, adult, donor10252	10155-103A2	58.67	2.63	0.31	2.48	4.33	2.17
medulla oblongata, adult, pool1	10038-101F2	44.00	0.41	0.41	2.37	0.65	0.65
medulla oblongata, newborn, donor10223	10361-105F1	28.47	1.39	0.35	1.39	0.69	0.69
medulloblastoma cell line:D283 Med	10838-111E1	41.40	2.44	0.66	1.77	1.11	1.11
medulloblastoma cell line:ONS-76	10759-110E3	53.68	0.86	0.86	0.37	0.73	0.61
melanoma cell line:COLO 679	10514-107E1	32.06	0.14	1.15	0.29	0.00	0.14
melanoma cell line:G-361	10465-106H6	25.52	0.54	0.54	0.54	0.27	0.54
meningioma cell line:HKBMM	10691-109F7	31.84	1.99	0.00	0.36	0.18	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	67.85	1.76	0.00	0.00	0.88	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	53.14	1.04	2.33	0.78	1.04	1.30
mesenchymal precursor cell - adipose, donor1	11747-123G1	33.76	0.15	0.15	0.77	0.61	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	28.72	0.73	0.18	0.36	0.36	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	20.71	0.41	0.83	0.41	0.00	1.24
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	24.72	1.12	0.56	0.42	1.69	0.56
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	24.65	0.19	0.00	0.58	0.77	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	15.96	2.08	0.00	0.00	0.69	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	17.51	0.69	0.69	0.00	0.17	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	24.84	0.58	0.23	0.35	1.50	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	22.55	0.40	0.53	0.13	0.40	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	25.93	0.41	0.95	0.00	0.68	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	37.27	0.71	1.42	0.43	1.56	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	25.36	1.32	0.00	0.99	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	31.69	0.42	0.83	0.69	1.94	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	31.77	0.70	1.05	0.00	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	27.97	0.61	0.41	0.41	0.20	1.02
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	27.32	0.36	0.72	0.00	0.36	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	19.76	0.00	0.10	0.21	0.93	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	19.61	0.46	0.46	0.46	0.23	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	31.89	0.84	0.42	1.68	0.00	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	32.73	0.15	1.05	0.60	1.05	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	27.75	0.53	0.79	0.18	1.40	0.61
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	25.77	0.37	0.00	0.37	0.37	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	35.77	0.86	0.86	0.29	0.86	1.43
mesenchymal stem cell line:Hu5/E18	10568-108B1	33.26	2.53	2.53	0.42	0.42	2.11
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	20.55	0.46	0.00	0.00	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	24.04	0.26	0.51	0.00	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	24.87	1.05	0.00	1.31	0.26	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	16.94	1.54	0.31	0.31	0.00	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	20.01	0.24	0.24	0.00	0.71	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	15.57	0.34	0.00	0.34	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	25.15	0.00	0.39	0.00	0.00	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	19.00	0.46	0.93	0.00	0.00	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	30.28	0.29	0.29	0.87	0.29	1.15
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	28.11	0.00	0.00	0.45	0.00	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	24.76	0.00	0.24	0.24	0.24	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	39.60	0.00	0.00	1.47	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	25.51	0.00	1.01	0.67	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	28.66	0.00	0.41	0.41	0.41	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	21.91	0.43	0.00	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	10.94	2.73	0.00	0.00	0.00	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	19.81	0.65	0.32	0.65	0.00	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	20.37	2.91	0.00	0.00	0.00	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	23.46	0.00	0.00	0.00	0.00	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	22.90	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	18.27	1.17	0.39	0.00	0.00	1.55
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	20.99	2.10	0.00	2.10	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	23.84	0.00	0.99	1.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	19.07	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	22.53	1.78	0.00	0.00	0.00	2.96
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	23.15	1.22	1.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	15.83	0.63	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	30.35	0.34	0.34	0.00	0.00	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	19.34	2.15	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	15.97	0.00	0.00	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	20.66	0.00	0.00	0.00	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	17.52	0.41	0.00	0.00	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	22.24	1.59	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	17.10	0.00	0.00	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	12.47	0.00	0.00	0.31	0.00	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	12.03	1.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	20.11	0.00	1.18	0.00	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	23.11	0.00	0.00	2.57	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	28.22	1.38	0.69	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	39.58	1.98	0.00	0.00	0.49	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	38.13	1.12	0.00	0.00	0.00	2.24
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	39.44	2.54	1.91	0.00	0.64	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	51.58	1.21	0.81	0.40	0.00	1.61
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	39.25	6.54	2.18	0.00	2.18	6.54
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	36.74	1.27	1.27	0.00	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	27.92	0.00	0.61	0.00	0.00	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	31.63	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	31.30	1.65	0.00	0.00	0.00	3.29
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	26.19	0.20	0.60	0.20	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	20.12	0.00	0.00	0.65	0.00	1.30
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	29.54	0.00	0.00	0.00	0.00	3.06
mesodermal tumor cell line:HIRS-BM	10696-109G3	35.59	0.00	0.00	0.00	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	92.61	0.47	0.71	0.94	0.71	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	51.20	0.93	1.16	0.00	0.46	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	81.20	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	67.92	1.54	1.54	0.41	1.03	1.44
mesothelioma cell line:Mero-25	10850-111F4	16.57	0.91	0.45	0.23	0.23	0.45
mesothelioma cell line:Mero-41	10851-111F5	56.96	1.71	0.73	0.98	1.22	2.93
mesothelioma cell line:Mero-48a	10852-111F6	46.94	1.11	1.55	0.89	0.66	0.66
mesothelioma cell line:Mero-82	10853-111F7	38.63	3.68	1.31	0.79	0.00	2.89
mesothelioma cell line:Mero-83	10854-111F8	55.66	2.21	1.36	0.68	0.51	2.38
mesothelioma cell line:Mero-84	10855-111F9	21.99	0.25	0.25	0.25	0.00	0.51
mesothelioma cell line:Mero-95	10856-111G1	32.92	1.24	0.41	0.41	0.00	1.24
mesothelioma cell line:NCI-H2052	10847-111F1	27.83	0.33	1.16	0.50	0.00	0.50
mesothelioma cell line:NCI-H226	10846-111E9	37.10	1.63	1.81	0.72	0.72	1.09
mesothelioma cell line:NCI-H2452	10848-111F2	62.52	0.85	1.37	0.68	0.68	1.37
mesothelioma cell line:NCI-H28	10845-111E8	35.88	0.76	0.51	0.25	0.25	0.76
mesothelioma cell line:No36	10857-111G2	27.73	0.00	0.65	0.00	0.00	0.98
mesothelioma cell line:ONE58	10858-111G3	30.35	2.98	0.81	0.00	0.00	1.35
migratory langerhans cells, donor1	11901-125F2	52.59	0.38	1.92	1.34	0.19	1.34
migratory langerhans cells, donor2	11902-125F3	54.22	0.61	1.22	1.59	0.49	0.49
migratory langerhans cells, donor3	11903-125F4	41.28	0.18	0.36	3.59	0.90	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	28.40	1.31	0.33	0.65	0.33	3.59
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	27.34	0.42	0.21	0.21	0.85	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	50.22	0.69	0.46	0.00	0.23	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	24.55	0.38	0.76	0.76	0.95	0.76
myelodysplastic syndrome cell line:SKM-1	10772-110F7	58.76	1.48	0.92	0.92	0.37	1.11
myeloma cell line:PCM6	10474-106I6	52.78	0.20	0.59	0.79	0.00	1.38
myxofibrosarcoma cell line:MFH-ino	10600-108E6	38.55	1.01	1.01	0.00	0.00	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	55.31	0.78	0.39	0.59	1.57	1.96
nasal epithelial cells, donor1, tech_rep1	12226-129F3	32.76	0.11	0.00	0.67	1.23	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	29.86	0.29	0.00	0.37	0.44	0.29
nasal epithelial cells, donor2	12227-129F4	27.05	0.00	0.00	0.00	1.10	0.00
neuroblastoma cell line:CHP-134	10508-107D4	47.62	0.46	0.69	0.46	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	41.72	0.19	0.94	0.37	0.37	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	111.56	6.33	8.01	1.48	3.16	2.95
neuroblastoma cell line:NH-12	10555-107I6	55.91	1.30	0.37	2.05	0.93	1.12
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	68.56	2.14	1.19	1.66	0.95	2.85
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	86.48	3.64	3.01	1.43	1.27	1.90
neuroectodermal tumor cell line:TASK1	10774-110F9	65.81	2.82	0.60	0.81	1.61	1.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	70.57	0.64	0.00	0.64	1.27	1.27
neurofibroma cell line:Hs 53.T	10729-110A9	39.92	0.80	1.60	0.53	0.53	0.53
neutrophil PMN, donor1	12133-128D9	163.62	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	28.41	0.00	0.00	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	118.89	1.18	0.51	5.07	0.51	0.68
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	32.02	0.00	0.00	0.00	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	29.50	0.64	0.96	0.64	0.00	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	30.74	1.58	1.05	0.00	0.00	1.05
nucleus accumbens, adult, pool1	10037-101F1	51.84	0.56	0.28	2.81	1.69	0.47
occipital cortex - adult, donor10196	10172-103C1	41.21	0.00	0.00	4.12	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	69.24	2.68	0.54	3.49	5.10	4.29
occipital cortex, newborn, donor10223	10355-105E4	25.48	1.09	0.73	0.73	0.00	0.36
occipital lobe, adult, donor1	10076-102A4	29.39	0.79	0.26	0.26	1.84	3.67
occipital lobe, fetal, donor1	10073-102A1	36.90	3.43	0.43	1.72	2.15	2.15
occipital pole, adult, pool1	10036-101E9	32.33	0.32	0.32	1.34	0.71	0.16
olfactory region, adult	10195-103E6	29.42	1.91	0.76	3.06	2.10	4.20
optic nerve, donor1	10277-104E7	36.02	0.00	0.00	0.00	0.00	6.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	45.79	0.46	0.46	0.57	0.23	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	69.65	0.96	0.41	1.37	0.27	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	57.23	5.25	1.35	0.17	0.51	2.88
oral squamous cell carcinoma cell line:SAS	10544-107H4	34.08	0.69	1.04	0.81	0.46	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	36.75	0.59	0.59	0.29	0.29	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	174.72	0.93	7.47	0.00	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	71.25	0.21	1.27	0.64	0.42	0.00
ovary, adult, pool1	10020-101D2	35.55	0.17	0.44	0.87	0.87	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	54.63	1.10	0.73	0.55	0.92	2.02
pancreas, adult, donor1	10049-101G4	37.63	0.94	0.00	0.94	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	29.63	0.00	1.68	0.84	0.28	0.84
papillary adenocarcinoma cell line:8505C	10437-106E5	32.37	2.90	0.68	0.00	0.00	2.21
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	36.26	0.17	0.66	0.17	0.00	0.17
paracentral gyrus, adult, pool1	10035-101E8	51.71	0.55	0.27	2.93	0.92	0.55
parietal cortex, adult, donor10258	10373-105G4	16.88	0.73	0.00	0.73	0.00	0.73
parietal lobe - adult, donor10196	10171-103B9	33.86	1.88	0.00	4.70	0.00	6.58
parietal lobe, adult, donor10252	10157-103A4	55.87	2.00	0.00	2.00	2.57	2.57
parietal lobe, adult, pool1	10034-101E7	56.93	0.70	0.53	1.76	1.59	0.18
parietal lobe, fetal, donor1	10072-101I9	48.49	7.76	0.00	0.00	2.91	5.82
parietal lobe, newborn, donor10223	10356-105E5	25.80	0.00	0.75	0.75	0.00	1.12
parotid gland, adult	10199-103F1	24.67	1.85	0.00	0.00	0.00	1.23
penis, adult	10200-103F2	41.89	1.61	0.00	1.61	0.00	4.83
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	69.73	0.74	1.12	1.67	0.00	1.49
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	19.96	0.58	0.15	0.29	0.44	0.58
pineal gland - adult, donor10196	10179-103C8	47.09	0.00	0.65	1.94	0.00	3.23
pineal gland, adult, donor10252	10160-103A7	101.86	2.37	0.00	6.51	5.92	2.96
pineal gland, adult, donor10258	10377-105G8	40.13	0.00	0.00	2.51	0.63	0.63
pituitary gland - adult, donor10196	10180-103C9	54.64	2.02	0.00	2.02	0.00	5.06
pituitary gland, adult, donor10252	10162-103A9	130.29	3.13	1.04	3.65	5.21	2.61
pituitary gland, adult, donor10258	10378-105G9	58.74	1.70	0.00	1.70	0.85	0.85
placenta, adult, pool1	10021-101D3	40.10	0.54	0.54	1.40	1.72	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	32.97	1.72	1.06	2.38	1.72	0.93
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	49.03	0.31	0.00	0.62	0.00	0.78
pons, adult, pool1	10033-101E6	48.54	0.60	0.69	2.75	1.38	0.43
postcentral gyrus, adult, pool1	10032-101E5	40.10	0.35	0.78	1.83	0.61	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	102.48	0.00	0.00	4.18	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	49.57	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	74.72	1.17	2.62	0.15	0.73	1.31
prostate cancer cell line:PC-3	10439-106E7	97.65	1.09	1.63	1.27	1.09	1.45
prostate, adult, pool1	10022-101D4	38.91	0.27	0.00	2.09	0.63	0.18
putamen, adult, donor10196	10176-103C5	60.90	2.83	0.47	3.30	2.36	4.01
putamen, adult, donor10252	10152-102I8	33.33	0.00	0.00	1.96	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	15.30	1.09	0.00	4.37	0.00	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	30.68	0.72	0.48	2.17	1.69	0.97
putamen, newborn, donor10223	10365-105F5	23.99	3.00	0.00	0.75	0.00	2.25
rectal cancer cell line:TT1TKB	10469-106I1	71.28	0.29	1.16	1.45	2.04	0.00
rectum, fetal, donor1	10067-101I4	25.04	1.39	0.00	0.00	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	32.22	0.64	0.00	0.42	0.21	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	22.37	0.83	0.00	0.00	0.00	0.41
retina, adult, pool1	10030-101E3	37.37	0.99	0.20	2.48	1.69	0.40
retinoblastoma cell line:Y79	10475-106I7	63.39	0.78	1.56	0.00	0.78	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	49.92	0.61	1.48	0.86	0.49	1.48
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	116.14	1.12	1.97	1.69	0.00	0.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	50.78	0.00	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	32.21	0.65	0.16	0.49	0.97	1.46
salivary acinar cells, donor2	11772-123I8	32.22	1.10	0.55	0.83	0.96	1.38
salivary acinar cells, donor3	11773-123I9	48.99	0.66	0.66	1.32	1.99	1.99
salivary gland, adult, pool1	10093-102C3	24.02	0.00	0.00	1.14	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	56.91	0.51	0.76	0.59	0.17	0.34
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	52.78	0.59	0.94	0.82	0.24	0.35
seminal vesicle, adult	10201-103F3	33.33	1.59	1.06	0.00	1.06	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	30.85	1.46	1.94	0.73	0.24	1.21
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	21.89	0.75	0.25	0.50	0.00	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	33.12	0.00	1.00	0.00	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	34.12	0.40	0.40	0.27	0.27	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	33.93	0.22	0.22	0.33	0.11	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	35.61	0.13	0.39	0.26	0.26	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	117.04	4.26	1.42	2.84	0.71	12.06
skeletal muscle, adult, pool1	10023-101D5	216.37	2.04	2.52	5.40	5.04	1.20
skeletal muscle, fetal, donor1	10066-101I3	21.11	3.02	0.00	0.00	1.01	2.01
skin, adult, donor1	10074-102A2	27.14	6.79	0.00	0.00	0.00	6.79
skin, fetal, donor1	10065-101I2	47.34	0.63	1.26	1.26	2.52	3.79
small cell cervical cancer cell line:HCSC-1	10800-110I8	23.68	0.00	0.33	0.33	0.00	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	44.44	2.84	1.58	0.32	1.58	2.52
small cell lung carcinoma cell line:DMS 144	10841-111E4	42.98	1.35	0.96	2.51	0.77	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	59.67	0.82	1.98	0.49	1.15	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	30.56	0.32	0.48	0.48	0.48	0.64
small cell lung carcinoma cell line:WA-hT	10562-108A4	47.72	1.31	1.74	2.40	0.22	1.96
small intestine, adult, pool1	10024-101D6	39.18	0.96	0.24	0.84	1.91	0.36
small intestine, fetal, donor1	10064-101I1	23.34	1.47	0.74	0.74	2.21	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	28.21	2.56	0.51	0.00	0.51	0.51
smooth muscle, adult, pool1	10048-101G3	33.34	2.07	0.26	1.81	0.78	1.81
somatostatinoma cell line:QGP-1	10781-110G7	75.58	0.80	1.07	0.54	0.27	1.07
spinal cord - adult, donor10196	10181-103D1	30.74	3.21	0.00	1.38	0.46	2.06
spinal cord, adult, donor10252	10159-103A6	57.96	1.18	0.00	4.73	2.76	1.58
spinal cord, adult, donor10258	10369-105F9	15.22	0.00	0.00	6.92	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	26.83	1.83	0.61	1.22	0.00	2.44
spinal cord, newborn, donor10223	10359-105E8	35.82	0.00	0.00	2.30	0.00	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	46.90	1.19	1.19	0.45	0.45	1.19
spleen, adult, pool1	10025-101D7	41.74	0.55	0.22	0.99	0.55	0.33
spleen, fetal, pool1	10044-101F8	44.42	0.16	0.48	1.59	0.72	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	43.06	0.21	1.04	0.52	0.00	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	48.23	1.14	0.38	0.57	0.57	0.76
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	41.93	2.80	0.35	1.05	0.00	3.84
squamous cell carcinoma cell line:T3M-5	10616-108G4	112.98	5.86	3.13	1.95	0.78	3.91
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	71.02	0.56	1.46	0.68	0.34	0.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	72.01	0.85	2.12	0.00	0.42	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	57.54	0.42	1.27	0.00	0.00	0.42
stomach, fetal, donor1	10062-101H8	34.18	1.07	0.00	2.14	3.20	0.00
submaxillary gland, adult	10202-103F4	36.46	0.00	0.00	0.00	1.14	1.14
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	108.55
substantia nigra, adult, donor10252	10158-103A5	59.61	2.08	0.21	1.87	3.95	2.28
substantia nigra, adult, donor10258	10371-105G2	17.59	0.00	0.00	2.59	0.52	0.52
substantia nigra, newborn, donor10223	10358-105E7	20.49	0.00	0.00	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	54.11	0.92	1.60	1.38	0.23	1.38
temporal lobe, adult, pool1	10031-101E4	32.89	0.68	0.42	2.71	1.02	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	54.13	2.85	0.71	1.42	0.71	2.14
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	39.56	0.88	0.44	1.32	0.00	0.88
tenocyte, donor1	11763-123H8	26.53	3.14	0.35	0.70	0.70	0.70
tenocyte, donor2	11765-123I1	17.55	0.38	0.38	0.38	0.00	0.00
tenocyte, donor3	11768-123I4	23.72	1.48	0.00	1.11	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	149.91	3.40	9.18	0.68	2.04	5.61
teratocarcinoma cell line:NCR-G1	10798-110I6	30.21	0.15	0.00	0.15	0.00	0.62
teratocarcinoma cell line:PA-1	10807-111A6	54.55	0.93	1.39	0.15	2.01	1.24
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	98.26	1.78	4.19	1.40	2.16	3.55
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	106.64	1.51	3.78	3.03	1.89	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	140.36	4.04	6.43	3.16	3.60	2.73
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	115.30	7.49	7.17	0.65	0.65	7.17
testis, adult, pool1	10026-101D8	36.83	0.97	1.40	5.15	2.68	0.86
testis, adult, pool2	10096-102C6	44.21	4.96	2.26	6.32	0.90	10.83
thalamus - adult, donor10196	10168-103B6	38.64	3.31	0.00	3.31	0.00	2.21
thalamus, adult, donor10252	10154-103A1	56.73	1.25	0.16	2.81	3.91	1.41
thalamus, adult, donor10258, tech_rep1	10370-105G1	12.32	0.00	0.00	4.62	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	14.33	1.32	0.49	0.49	0.16	0.49
thalamus, newborn, donor10223	10366-105F6	23.59	0.00	2.30	1.73	0.00	0.58
throat, adult	10209-103G2	60.92	2.00	1.25	1.25	1.50	2.00
throat, fetal, donor1	10061-101H7	33.21	2.44	0.30	1.52	1.83	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	42.33	0.00	0.60	0.40	0.79	0.99
thymus, adult, pool1	10027-101D9	62.53	1.19	0.99	2.39	2.39	0.89
thymus, fetal, pool1	10043-101F7	85.20	0.83	0.73	4.05	2.18	0.62
thyroid carcinoma cell line:KHM-5M	10776-110G2	28.85	0.66	0.40	0.13	0.00	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	68.31	1.54	0.84	0.42	0.70	1.40
thyroid, adult, pool1	10028-101E1	36.95	0.28	0.37	1.68	1.31	0.09
thyroid, fetal, donor1	10060-101H6	32.69	0.79	0.26	0.53	2.64	1.32
tongue epidermis (fungiform papillae), donor1	10288-104F9	40.04	6.16	0.00	0.00	0.00	3.08
tongue, adult	10203-103F5	56.75	2.79	0.47	2.79	0.00	2.09
tongue, fetal, donor1	10059-101H5	56.36	4.34	0.39	1.18	2.36	2.76
tonsil, adult, pool1	10047-101G2	53.19	0.40	0.10	1.40	1.00	0.20
trachea, adult, pool1	10029-101E2	46.87	0.57	0.41	1.15	1.15	0.16
trachea, fetal, donor1	10058-101H4	25.39	0.77	0.00	1.15	2.69	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	36.49	1.42	0.71	0.35	0.35	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	51.87	0.61	1.11	1.32	1.01	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	105.14	2.66	0.94	2.35	0.78	0.78
tridermal teratoma cell line:HGRT	10694-109G1	43.76	0.00	0.00	1.90	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	31.74	0.59	0.93	0.59	0.08	0.68
umbilical cord, fetal, donor1	10057-101H3	29.21	0.00	0.00	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	33.96	0.00	0.34	3.92	0.34	0.17
uterus, fetal, donor1	10055-101H1	31.23	2.05	0.00	0.00	0.51	2.56
vagina, adult	10204-103F6	46.53	0.00	0.00	0.00	0.65	0.00
vein, adult	10191-103E2	28.28	1.10	0.22	1.53	1.32	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	29.64	0.80	0.00	0.27	0.53	1.60